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CHAPTER 1 - STROKE INTRODUCTION AND MITOCHONDRIAL MECHANISMS OF
ISCHEMIA/REPERFUSION INJURY
Stroke: Background, Anatomy and Gross Pathophysiology
Focal brain ischemia, i.e., stroke, is one of the leading causes of death and
disability in the Western world.(Feigin, Norrving, and Mensah 2017) These
cerebrovascular events are normally subdivided into hemorrhagic and ischemic strokes.
Hemorrhagic strokes occur when an intracranial vessel ruptures, filling the subdural,
subarachnoid or intracerebrum with blood and account for about 6.7% of stroke
presentations to the Emergency Department. Ischemic strokes, on the other hand, occur
when a blood vessel becomes occluded thus cutting off the adjacent brain tissue from
critical blood supply. Most occlusions are cardioembolic, resulting from underlying cardiac
arrhythmias such as atrial fibrillation, or congenital heart abnormalities such as a patent
foramen ovale but these are not the only causes.(Chung J‐W Fau - Chung et al. 2014)
Large vessel atherosclerosis in the internal carotid artery, as well small vessel disease
resulting from uncontrolled hypertension can all lead to focal brain lesions.(Chung J‐W
Fau - Chung et al. 2014)
Neurons rely almost entirely on oxidative phosphorylation to meet their high
metabolic demands and so any disruption of blood supply to an area of the brain causes
rapid, irreversible neuronal death.(Attwell and Laughlin 2001; Yellen 2018) For this
reason, swift stroke intervention is needed in the clinic to restore blood supply to the
affected tissue and thus save neurons – and by extension reduce stroke mortality and
disability. To date, the only clinically approved therapies to reverse the ischemia and
restore blood flow which carries crucial oxygen and metabolites to the starved neurons
are either pharmacological, in the form of tissue plasminogen activator (tPA) or surgical
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as seen in endovascular thrombectomy.('Tissue Plasminogen Activator for Acute
Ischemic Stroke' 1995; Hacke 2015) Both of these interventions have been correlated
with improvement in stroke outcomes though only a relatively small subset of the stroke
patient population meets the stringent criteria to receive such treatments.
Affected ischemic brain tissue, however, cannot be considered homogenously.
The anatomy and physiology of cerebral blood supply allows for tight regulation during
vast physiological and pathophysiological fluctuations of cerebral blood flow. The brain
receives its blood from four major vessels, two of which branch off the subclavian arteries
and two directly from the aorta. The former, the carotid arteries, bifurcate in the neck into
the external which courses into the face and the internal which inters at the base of the
brain. The two vertebral arteries run parallel to the vertebral column and join together at
the base of the brain to form the basilar artery. These arteries, along with adjoining
“communicating arteries” form an anastomosis that was named after the famous
physician Thomas Willis – forming the Circle of Willis. Of note, the internal carotid artery
forms the origin of the middle cerebral artery (MCA) which supplies blood to the cortex
through its cortical branches, as well as to the striatal subcortical structures through its
lenticulostriate branches.(Liebeskind 2003) There are thus six arteries that supply blood
to the brain: the right and left anterior, middle, and posterior cerebral arteries which are
connected within the Circle of Willis by the communicating arteries at the origins, and by
Heubner’s leptomeningeal anastomoses at their distal ends. Thus, any extra-cranial
occlusion of one artery results in adequate perfusion throughout the brain through the
other six arteries. This very elegant system ensures that the brain receives a constant
supply of blood.(Hossmann 2009)
When an occlusion of one of these arteries within the brain takes place, neurons
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directly proximal to the occluded vessel that receive their blood supply from it rapidly
deplete their ATP stores and become at risk for dying in the absence of immediate
intervention. Because neurons rely so heavily on mitochondrial ATP to maintain their ionic
gradients, any disruption in oxidative phosphorylation leads to ionic equilibration,
especially sodium, across the membrane resulting in rapid depolarization as well as an
influx of water leading to cytotoxic edema.(Rungta et al. 2015) However, sodium is not
the only ion to move down its concentration gradient into the cell, calcium also rapidly
flows in, taxing the already dysfunctional mitochondria and initiating delayed neuronal
death cascades – a crucial factor in disease progression.
In 1977 Astrups et al. published a seminal study in which they provided
electrophysiological evidence that following focal brain ischemia in the primate brain,
evoked cortical potentials could be transiently abolished in a manner directly related to
the rate of blood flow.(Astrup J Fau - Symon et al. 1977) Simply put, as blood flow fell
below critical thresholds, recovery of neuronal activity became more difficult. But, moving
away from this core of inactivity directly proximal to the occlusion resulted in a zone of
transient electrical quiescence that could be reversed upon restoration of flow to
physiological levels. When collateral flow to these neurons was increased by increasing
systemic blood pressure, these neurons could once gain reach action potential. Perhaps
even more interestingly, it was noted that if ischemia were to persist beyond a critical
window, even these neurons would undergo anoxic depolarization and subsequently die.
Thus, it was found that regions of focal brain ischemia contained neurons that died in a
flow-dependent and time-dependent manner. Astrups et al. called this area the penumbra
and it came to be defined as a hypoperfused area of the parenchyma that was fed by
collateral flow that was shunted to the area through changes in arterial pressure and local
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factors.(Astrup, Siesjö, and Symon 1981) Because these neurons do not initially die they
could be potentially salvaged by a therapeutic intervention.
This was a shocking discovery that is anatomically intuitive: moving away from the
occlusion, neurons receive retrograde flow from Heubner’s pial anastomoses and thus
remain potentially viable. Much research has been conducted following Astrups’ study to
determine the viability of these neurons based on the rate of blood flow they
receive.(Astrup, Siesjö, and Symon 1981; Mies et al. 1991; Hossmann 2009) Different
neuronal functions break down across the ranges of flow reduction. It has been shown,
for example, that protein synthesis is reduced by 50% when cerebral blood flow rates
drop to 0.55 ml/g/min and stops below 0.35 ml/g/min. Anoxic depolarization takes place
at much lower flow rates – at 0.06 - 0.15 ml/g/min extracellular ion changes, including but
not limited to extracellular reductions in calcium due to the opening of calcium
channels.(Hossmann 2009) Thus, rather than being a homogenous region, the ischemic
parenchyma can be thought of as a shadowy zone in which neurons are undergoing
multifaceted dysfunction depending on the extend of blood flow reduction.
Taken together, stroke therapy seeks to restore blood supply and save these
penumbral neurons. However, re-oxygenation results in substantial tissue damage due
to the production of Reactive Oxygen Species (ROS).(Granger and Kvietys 2015)
Ischemia-reperfusion injury has proven to pose a perplexing clinical problem: while rapid
restoration of blood is crucial in salvaging the penumbra, doing so can exacerbate brain
injury due to the production of ROS.(Carden and Granger 2000; Raedschelders, Ansley
Dm Fau - Chen, and Chen 2012)
Role of Mitochondria in Ischemia Reperfusion Injury
Studies have shown that the mitochondria play a pivotal role in the production of ROS
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which goes on to further damage cells during reperfusion, but their role is not limited to
this.(Murphy 2009) Mitochondria also initiate type II apoptosis through the release of
apoptogenic proteins such as cytochrome c, APAF-1 and SMAC-DIABLO which lead to
a cell death phenotype similar to apoptosis known as delayed neuronal death.(Green and
Reed 1998) In what follows, we shall discuss mitochondrial mechanisms of cerebral
ischemia reperfusion in greater detail, and outline unique findings in the HüttemannSanderson laboratories that allow for the convergence of these mechanisms on the
complex regulation of the mitochondrial membrane potential.
Oxidative Phosphorylation Summarized
A single molecule of glucose produces 38 ATP molecules: 2 from glycolysis, 2 from
the Krebs cycle, and 34 from oxidative phosphorylation via the mitochondrial electron
chain. Thus, oxidative phosphorylation plays a critical role in providing sufficient ATP to
meet the cell’s energy demands.(Krebs et al. 1953)
Glucose is fully oxidized during glycolysis and the TCA cycle, the latter of which
takes place in the mitochondrial matrix.(Krebs et al. 1953) Energy is then stored in the
reduced electron carriers NADH and FADH2. These two carries donate their electrons to
the complexes of the electron transport chain and are then passed from complex to
complex which is coupled to proton pumping from the matrix to the intermembrane space.
There are two primary sites through which electrons enter the electron transport chain:
complex I (NADH dehydrogenase), and complex II (succinate dehydrogenase).
Mammalian complex I is comprised of about 45 subunits, containing Flavin
mononucleotide (FMN) that is not covalently bound and serves as the point of entry for
electrons, and an iron-sulfur clusters.(Lenaz et al. 2006) When NADH is oxidized, two of
its electrons are eventually transferred to ubiquinone (Coenzyme Q, CoQ).(Hirst et al.
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2003; Sazanov 2007) Complex I is also a major site of ROS production.(Murphy 2009)
Based on bacterial studies, there are seven iron sulfur clusters that pass electrons from
FMN to CoQ.(Sazanov 2007) When O2 reacts will the reduced FMN, superoxide can form,
though this is not the primary mechanism of ROS production during reperfusion which
likely occurs due to the semiquinone free radical which will be discussed below. It is also
worth noting that the reduction state of FMN is determined by the NADH/NAD+
ratio.(Kussmaul and Hirst 2006; Murphy 2009; Hirst, King Ms Fau - Pryde, and Pryde
2008) Thus, any changes in this ratio by, say, ischemia will increase the NADH/NAD+
ratio and result in superoxide being formed. It must be noted that an additional mechanism
of ROS formation by complex I occurs during reverse electron transport (RET).(AdamVizi and Chinopoulos 2006; Kudin et al. 2004; Votyakova 2001; Liu, Fiskum G Fau Schubert, and Schubert 2002) This occurs when the CoQ supply is reduced by electrons
and when the proton motive force is large enough to push electrons back from CoQH2
into complex, reducing NAD+ to NADH.(Chance 1961) Moreover, when substrate
succinate concentrations are high, RET can take place through complex I.(Liu, Fiskum G
Fau - Schubert, and Schubert 2002) What is significant to this study about RET is the
directly responsibility of Δpm and thus even small reductions in Δpm can halt the entire
process by reducing the electrostatic forces that drive electrons to the sits where
superoxide might be produced.(Lambert 2004; Votyakova 2001) Further noteworthy is
that complex I produces ROS in proportion to the pH gradient rather than the membrane
potential.(Lambert 2004; Liu 1997; Murphy 2009)
From complex I, electrons are transferred to complex III (bc1 complex) via the
electron carrier ubiquinone.(Mitchell 1975b, 1975a; Crofts 1998, 2004; Trumpower 1976;
Chobot 2008; Osyczka 2005) It is necessary to outline the Q cycle in some detail as
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complex III is a site of ROS generation.(Cadenas E Fau - Boveris et al. 1977; Turrens,
Alexandre, and Lehninger 1985) Briefly, ubiquinol (QH2) binds to the Qo site of complex
III while ubiquinone binds to the Qi sight. Ubiquinol then gives up its electron to the ironsulfur cluster of the enzyme and to the bL heme group. This oxidation reaction results in
the generation of a temporary radical, semiquinone which goes on to become completely
oxidized forming ubiquinone, which leaves the Qo binding site – and it is in fact center P
of the Qo site where superoxide is most formed by complex III. The iron-sulfur cluster
which has received one electron from ubiquinol, loses the electron and then translocates
to the cytochrome c1 subunit where it donates its electron to cytochrome c which then
dissociates from complex III. Furthermore, oxidation of the iron-sulfur cluster also
releases a proton into the intermembrane space which comes from Q10. The additional
electron reduces the bH heme which then transfer it to the second ubiquinone molecule
at the Qi site. This electron must move against its electrical gradient because it must go
to the negatively charged membrane. Ubiquinone then becomes reduced to the
semiquinone radical which requires a second Q cycle to transfer an electron to reduce
semiquinone to ubiquinol. Thus, in summary, the Q cycle pushes four protons into the
intermembrane space. From here, cytochrome c carries its electrons which are bound to
the heme group to complex IV. Cytochrome c also has a role in apoptosis, which shall be
discussed in greater detail below.
The combination of moving electrons and pumping protons generates the protonmotive force which is the crux of the chemiosmosic hypothesis first formulated by Peter
Mitchell which drives oxidative phosphorylation as it converts electro-chemical energy
into mechanical energy.(Mitchell and Moyle 1967) This process produces the proton
motive force, Δpm which is comprised of the electrical component known as the
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mitochondrial membrane potential (ΔΨm) and the chemical component which is the pH
difference across the inner mitochondrial membrane. The proton motive force can be
outlined according to the following equation: Δpm = ΔΨm - 59ΔpH and in higher organisms,
the electrical potential (ΔΨm) is the major driver of the proton motive force. In intact
mitochondria, the protons that have accrued in the intermembrane space enter into the
Fo complex of ATP-synthase and exit through the matrix. Their stored potential energy is
converted to kinetic energy as they rush down their concentration gradient, clockwise
rotating Fo and the stalk (around 6000 rpm). This rotation induces conformational changes
in the head proteins that force ADP and Pi close enough together to bind thus forming
ATP. ATP is then transported out of the matrix by a group of mitochondrial carrier proteins,
specifically ATP/ADP translocase.
OxPhos Regulation
The electron transport chain has evolved in such a way as to allow the cell to meet
its energy demands according to its needs. In order to achieve this goal, the functions of
the ETC must be carefully regulated by a number of mechanisms. As we have seen, the
proton motive force drives ATP production through a carefully orchestrated sequence of
steps in which electrons are passed between ETC complexes and protons are shuttled
into the intermembrane space thus generating an electrochemical gradient that powers
complex V, ATP-synthase. Classically, the proton motive force and the mitochondrial
membrane potential are regulated by the amount of substrate present and respiratory
control.
At their core, the enzymes of the ETC are regulated by the presence or absence
of substrate or product.(Arnold and Kadenbach 1999; Kadenbach et al. 2010) ATP and
ADP can activate or inhibit cytochrome c oxidase (CcO), respectively, according to the
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cell’s energy needs. When ATP binds to cytochrome C, the reaction between cytochrome
c and cytochrome c oxidase is curbed. CcO is modulated by the presence of ATP/ADP
by means of its binding pocket located in the matrix domain and resulting in the inhibition
of the enzyme when ATP is present and activation when there is more ADP.
In addition to the presence of substrate or product, the proton motive force itself
regulates respiration by a process known as respiratory control. Originally demonstrated
in the 1950s in isolated mitochondria, respiratory control occurs when the proton motive
force itself inhibits the proton pumps of the ETC once the proton gradient passes a certain
threshold thus not allowing for further protons to be pumped when Δpm is high.(Chance
B Fau - Williams and Williams 1955) In vivo, the reduction of the proton gradient because
of ATD + Pi being converted to ATP by complex V allows the proton pumps to reinitiate
electron transfer and proton pumping. In situations of excess of ATP, such as resting
mitochondria, Δpm increases to an inhibitory threshold and thus proton pumping ceases
and so does respiration. This mechanism, which is connected to electron transport and
thus ΔΨm allows for tight regulation of mitochondrial membrane potential between 80 and
140 mV which optimizes energy production and minimizes ROS.(Sanderson et al. 2013)
While these basic mechanisms govern respiration in both prokaryotic and
eukaryotic organisms, in recent years it has been demonstrated that higher eukaryotic
organisms exhibit additional levels of respiratory control. Evidence for this can be found
in increased complexity of eukaryotic ETC complexes – e.g., bacterial CcO contains 2-4
subunits whereas mammalian CcO is comprised of 13 subunits for each monomer and
operates as a dimer.(Tsukihara et al. 1996; Huttemann et al. 2008)
As we have seen, Cyt c transfers electrons from the bc1 complex to cytochrome c
oxidase and in recent years has been shown to be subject to modulation by intracellular
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signaling cascades. Specifically, studies on isolated enzyme have shown several
phosphorylation sites. Lee et al. found that phosphorylation of cow heart Cyt c resulted in
inhibition of the enzyme thus providing evidence for post-translational enzymatic control,
and the inhibitory effect of phosphorylation.(Lee et al. 2006) Perhaps further solidifying
this point were in vitro analyses performed by the Hüttemann lab with isolated enzyme
from cow liver.(Yu et al. 2008) The group examined the Tyr-48 phosphorylation site and
found that when phosphorylated, the maximal turnover of Cyt c was 3.7/sec; however,
when the enzyme was dephosphorylated, activity increased drastically to 8.2/sec which
amounted to a 2.2 fold increase. Thus, it can be concluded from these studies that the
maximum number of chemical conversions of the substrate per second that a single
catalytic site of Cyt c can complete decreases when the enzyme is phosphorylated and
drastically increases upon dephosphorylation – a phenomenon which occurs during
periods of cellular stress (brain ischemia, in particular).(Huttemann et al. 2008)
Having seen that Cyt c can be reversibly phosphorylated and deposphorylated and
this activity can alter enzymatic reaction rates, the next question for us to ask is whether
other ETC enzymes capitulate to the same principles. Of interest to this work in particular
is how cytochrome c oxidase can be affected by phosphorylation/dephosphorylation.
Early studies have shown in rat heart mitochondria that CcO can be phosphorylated by
at residue Tyr304(Steenaart and Shore 1997); however, many of the early experiments
failed to show the relevance of CcO phosphorylation because the enzymes had been
removed from their native cellular environment. To address these shortcomings, the
Hüttemann lab used liver issue to look at the cAMP signaling pathway and its effect on
CcO activity. They found that high levels of cAMP resulted in the phosphorylation of the
enzyme. Perhaps even more interestingly, once phosphorylated, enzymatic activity was
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strongly inhibited even in the presence of high, non-physiological levels of substrate, 10
μM cytochrome c.(Lee et al. 2005) Furthermore, the cAMP pathway appears to be tissuespecific. Relevant to this study is the finding that under conditions of ischemia, CcO
changes its phosphorylation state as was shown in rabbit heart.(Fang et al. 2007; Prabu
et al. 2006) Guo et al (2007) showed that hypoxic stress induces increases in protein
kinase C (PKC) signaling, specifically the PKCε isoform.(Guo et al. 2007) PKCε was
found to co-localize with CcO during ischemia and its presence resulted in increased
activity.(Ogbi and Johnson 2006; Ogbi et al. 2004) Furthermore, Ty304 on CcO was found
to be reversibly phosphorylated where deposphorylation resulted in increased enzyme
activity.(Huttemann et al. 2008)
The theory, then, is that cellular stress, like ischemia, causes changes in the
phosphorylation states of the ETC complexes. In general, when the OxPhos enzymes are
phosphorylated, they are inhibited thus reducing proton pumping and maintaining the
membrane potential between 80 and 140 mV. However, during times of cellular stress,
enzymes are dephosphorylated or change their phosphorylation state, which rapidly and
drastically increases their activity, hyperpolarizing the membrane. Thus, ETC complexes
can be found in multiple states of phosphorylation that directly regulates their activity.
Hüttemann et al. argue that complexes I, III, and IV (which are the proton pumping
complexes) undergo structural changes upon phosphorylation so that already
intermediate (physiological) membrane potentials lead to inhibition of proton
pumping.(Huttemann et al. 2008) When these complexes are dephosphorylated,
however, they become maximally active and the membrane potential can only inhibit
proton pumping once it has reached much higher pathological levels.
Membrane Potential and ROS
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The mitochondrial membrane potential is tied to activation states of the OxPhos
complexes and the production of ROS under conditions of cellular stress. The
electrochemical gradient, or proton motive force, is comprised of the mitochondrial
membrane potential, ΔΨm, and the pH difference across the membrane due to the proton
pumping (the inner membrane being highly impermeable to protons). The electrical
component, which is the greatest contributor to the proton motive force in mammals, can
be measured using voltage-dependent fluorescent dyes such as tetramethylrhodamine
methyl ester (TMRM).
While there are species and tissue specific differences in ΔΨm, generally the
membrane potential during physiological conditions is kept between 80 and 140 mV.
Moreover, Hüttemann et al. have argued that reversible phosphorylation, which was
discussed in detail in the previous section, is the mechanism by which ΔΨm is
regulated.(Huttemann et al. 2008)
Under normal physiological conditions oxygen is fully reduced to H2O by CcO with
only a small number of electrons leaking and reacting with O2 to form superoxide.
Superoxide is produced at complexes I and III and is released mostly into the matrix by
complex I and the intermembrane space by complex III. In both cases, superoxide
generation has been shown to be dependent on membrane potential. When ΔΨm is
maintained within physiological range, ROS is minimized and ATP production can
proceed as needed. Moreover, it must be noted that any ROS that is produced at low
ΔΨm takes place by mechanisms other than membrane potential.(Suski et al. 2012) Thus,
ROS are formed by complexes I and III at higher membrane potential and, relevant to this
study, are exponentially produced when the membrane is hyperpolarized (that is, greater
than 140 mV).(Liu 1999; Starkov and Fiskum 2002; Liu 2010; Korshunov, Skulachev Vp
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Fau - Starkov, and Starkov 1997) In complex III, once the half-life of semiquinone radical
at the Qo site is extended by ΔΨm, the radical is able to react with dioxygen to form
superoxide.(Song and Buettner 2010)
Superoxide, once generated, reacts with water to generate H2O2 or protons to
produce even more ROS such as peroxides and hydroxyl radicals. ROS destroy cells as
they damage DNA, RNA, proteins, and lipids. Moreover, the half-life of most radicals is
very short ranging from nanoseconds to seconds.
Role of Mitochondrial Metabolites in ROS Production
A compelling study was performed by Couchani et al. in which they investigated
whether mitochondrial ROS during ischemia/reperfusion injury were produced by
metabolites.(Chouchani et al. 2014)

To interrogate their hypothesis, they utilized a

metabolomics approach in which they quantified conserved metabolites in several tissues
during ischemia/reperfusion injury. Using liquid-chromatography-mass spectrometry on
tissues harvested from pig brain, kidney, liver, and heart that underwent in vivo ischemia,
they found three primary metabolites elevated in all tissues: xanthine, hypoxanthine, and
succinate. Of the three, succinate was increased the most.
Succinate that had accrued during ischemia returned to normal levels within 5
minutes in ex-vivo tissue and in in vivo hearts. Furthermore, succinate accumulations
occurred in areas that had undergone ischemia and were marked by a striking absence
of other Krebs Cycle metabolites. It was thus concluded that succinate accumulates
rapidly during ischemia and is metabolized when flow is re-established which happens to
correspond to the same time-frame as ROS production.
Succinate is produced in the mitochondria during the Krebs cycle and via the
GABA shunt. Using radio-labeled carbon, Couchani et al. concluded that succinate

14
accumulation during ischemia does not take place from the usual carbon sources of
metabolism. The group next examined whether in situations of anoxia leading to
anaerobic metabolism, succinate dehydrogenase can reverse itself, reducing fumarate to
succinate(Niatsetskaya et al. 2012; Taegtmeyer 1978) – a concept that has not yet been
shown in ischemia. It was predicted that fumarate comes to SDH via the malate/aspartate
shuttle in which the NADH/NAD ratio is high thus forming malate which is eventually
converted to fumarate;(Hochachka Pw Fau - Storey and Storey 1975; Easlon et al. 2008;
Barron, Gu L Fau - Parrillo, and Parrillo 1998) and, the activation of the purine-nucleotide
cycle (PNC) that produces fumarate.(Van den Berghe, Vincent Mf Fau - Jaeken, and
Jaeken 1997; Sridharan et al. 2008) When the group used the SDH competitive inhibitor
dimethyl malonate, they saw a sharp decrease in succinate accretion in areas of ischemia
thus supporting the hypothesis that ischemia drives SDH backwards.(Chouchani et al.
2014) Moreover, using radio-labelled aspartate, it was found that ischemic tissue
activates both the malate/aspartate shuttle (MAS) and purine nucleotide cycle (PNC)
pathways to increase the amount of fumarate that is produced, which in turn is converted
to succinate by SDH working backwards.
It was hypothesized that during reperfusion, the accrued succinate becomes
oxidized by SDH and because the complexes were already hyperactive, reverse electron
transport becomes driven through complex I.(Hirst, King Ms Fau - Pryde, and Pryde 2008;
Kussmaul and Hirst 2006; Pryde and Hirst 2011; Murphy 2009) This is compelling,
because it has been previously shown that succinate can induce RET through complex I
in cell culture models(Murphy 2009). Using the ΔΨm fluorescent marker TMRM, the group
discovered that when SDH was inhibited with dimethyl malonate, the membrane potential
repolarization was significantly abated thus concluding that succinate accumulation in
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combination with a higher than normal proton motive force leads to RET through complex
I.(Chouchani et al. 2014)
Using these findings, Couchani et al. proposed the following model for the role of
metabolites in IR injury:(Chouchani et al. 2014) When tissue becomes ischemic, fumarate
increases because the MAS and PNC pathways become active. Fumarate is then
reduced to succinate when SDH works backwards. When blood flow is restored, the
excess succinate is quickly oxidized which generates a larger proton motive force due to
electrons being shunted through complexes III and IV, while simultaneously RET is
advanced through complex I thus producing ROS. In total these studies demonstrate the
central role of succinate as a key energy source driving mitochondrial ROS following
ischemia, with high ΔΨm required to generate and release these deleterious radicals.
Thus, dephorphorylation of ETC complexes leads to high membrane potential which
when combined with reversed electron transport leads to the post-reperfusion ROS burst.
Model of Brain Ischemia/Reperfusion Injury
Quick restoration of blood flow during brain ischemia is of critical importance;
however, doing so can exacerbate neuronal injury through the generation of ROS upon
reperfusion. Having discussed above how the OxPhos complexes function and are
regulated through reversible phosphorylation, and the role of the mitochondrial membrane
potential in ROS generation, we are now able to describe a mitochondrial model for
cerebral reperfusion injury. Because neurons rely nearly entirely on OxPhos, the
mitochondria of ischemic neurons are starved of their substrate, oxygen; however,
ischemia itself creates a double-edged sword in which oxygen-starved mitochondria
become primed for hyperactivation.
One of the most energy expensive processes in neurons is the maintenance of
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ionic gradients. Certainly, a high extracellular sodium and a high intracellular potassium
concentration are critical for neuronal function in the generation of action potentials but
these are not the only cations that must be carefully regulated by the cell – a difference
achieved by the sodium/potassium ATPase. When the sodium/potassium pumps fail due
to the cellular energy failure that occurs during ischemia, ions move down their
concentration gradients: sodium rushes into the cell and potassium exits until they
equilibrate across the membrane. This movement of sodium into the cell results in
depolarization of the cell membrane which opens voltage gated calcium channels.
Because the concentration of calcium is much higher extracellularly than intracellularly
(10 mM vs. 0.0001 mM), calcium rushes into the cell. Under normal physiological
conditions, transient depolarizations and intracellular calcium movement is critical for the
docking of neurotransmitter-containing vesicles with the membrane and the release of
their contents into the synaptic cleft; however, in ischemia, calcium accumulates in the
cytosol, unable to be eliminated by ATP-dependent Ca2+ pumps. Furthermore,
mitochondrial calcium sequestration through the mitochondrial calcium uniporter (MCU)
takes place, but under physiological conditions, most calcium is eliminated through
cytosolic rather than mitochondrial pathways.(Williams et al. 2013) This occurs because
the MCU affinity for calcium is quite low and requires very high cytosolic calcium
concentrations for transport of calcium into the mitochondria. In the case of ischemia, due
to both the failure of the ATPases to remove calcium, as well as the unimpeded movement
of calcium down its concentration gradient, cytosolic calcium increases.(Bourdillon Pd
Fau - Poole-Wilson and Poole-Wilson 1981) As intracellular calcium increases, MCUs
become active and sequester calcium into the mitochondria where it signals several
deleterious pathways, one of which being programed cell death, which will be reviewed
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in the following section.
The increased intermitochondrial calcium concentration activates phosphatases
that dephosphorylate complexes and proteins, especially cytochrome c and CcO. This
dephosphorylation leads to the OxPhos complexes being primed for hyperactivation even
in the absence of the substrate oxygen and leads to a loss of allosteric inhibition by ATP.
As we have seen, hyperpolarization of the membrane results in exponential ROS
production.(Liu 1999) Liu et al., and Starkov have clearly demonstrated that once
membrane potential exceeds just 10 mV beyond the physiological 140 mV, 70 - 90 %
increases in ROS follow.(Starkov and Fiskum 2002; Suski et al. 2012) Thus, the
dephosphorylation of OxPhos proteins during ischemia results in enormous ROS bursts
when reperfusion occurs due to a high membrane potential.
Once reperfusion is initiated, the deposphorylation of the complexes should serve
to quickly restore membrane potential leading to the replenishment of ATP. This is
sensible since deposphorylation causes them to work in overdrive thus reversing any
depolarization that occurred due to lack of both electrons and the final substrate, oxygen.
This was convincingly shown by Liu et al. who found that in brain ischemia, when blood
flow was restored, the membrane potential returned to normal levels within 30 to 60
minutes.(Liu 1999) However, when allosteric regulation is lost, the membrane potential
overshoots so to speak and dangerous hyperpolarization ensues. Moreover this has been
confirmed by cell culture models of ischemia/reperfusion injury.(Iijima et al. 2006) Another
interesting set of experiments conducted by Choi et al. (2009) found that blockade of
complex I during reperfusion, halted membrane hyperpolarization and drastically reduced
ROS formation.(Choi et al. 2009) These findings confirm what was discussed above
regarding the exponential relationship between ΔΨm and ROS production.
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Studies looking at global brain ischemia have found that ROS bursts typically occur
more intensely during the first 15 minutes of reperfusion(Kunimatsu et al. 2011) and these
ROS have been shown to originate from the mitochondria(Piantadosi and Zhang 1996;
Fabian, DeWitt Ds Fau - Kent, and Kent 1995; Kudin, Malinska D Fau - Kunz, and Kunz
2008)– specifically complex I in neurons.(Kudin, Malinska D Fau - Kunz, and Kunz 2008;
Barja and Herrero 1998; Barja 1999; St-Pierre et al. 2002)
In conclusion, membrane hyperpolarization due to OxPhos complexes being
primed for hyperactivation due to changes in their phosphorylation states leads to
exponential production of ROS during the early stages of reperfusion in brain ischemia.
Furthermore, as demonstrated by Choi et al, directly targeting the membrane potential
during reperfusion can have dramatic effects on the amount of ROS produced. Thus,
modulation of membrane potential can serve as a potential therapeutic strategy for brain
ischemia/reperfusion injury.
Delayed Neuronal Death
Cell death has classically been characterized as either necrotic or apoptotic based
on morphology. Necrosis, until very recently, was considered an unregulated pathway
(Proskuryakov, Konoplyannikov Ag Fau - Gabai, and Gabai 2003) although it is now
believed to arise from converging pathways. Morphologically cells dying by necrosis are
identifiable by cell membrane rupture and spilling intracellular contents once they have
been exposed to a stressor that pushes them beyond a threshold of recovery.
Apoptosis, in contrast, is a cell death paradigm that is executed and is classically
subdivided into two pathways. Type I (extrinsic) apoptosis is activated either by death
ligands (by the tumor necrosis factor (TNF) family proteins) that bind to extracellular
receptors, or by disengagement of life ligands (such as netrin). Once death ligands bind,
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they initiate a series of cell signaling pathways that ultimately result in programmed cell
death that can either be mitochondrial dependent or not. Type II (intrinsic) apoptosis
occurs when intracellular signals get transduced to the mitochondria and cause the
release of apoptogenic factors that lead to apoptosis. Furthermore, the intrinsic pathway
can be subdivided into caspase dependent and caspase independent mechanisms.
Caspase dependent apoptosis requires cytochrome c to be released from the
mitochondria which can involve the formation of the mitochondrial permeability transition
pore (MPTP) or mitochondrial outer membrane permeabilization (MOMP). Under normal
conditions a fraction of the cytochrome c pool remains bound to the inner mitochondrial
membrane lipid cardiolipin. Due to peroxidation of cardiolipin during cell stress (often by
ROS), cytochrome c dissociates and exits the mitochondria through the MPTP or MOMP.
Moreover, once released, cytochrome c interacts with the IP3 receptor on the
endoplasmic reticulum (ER) which causes the ER to discharge calcium into the cytosol.
Calcium, as we have seen, leads to more cytochrome c release triggering a positive
feedback loop. Once in the cytosol, Cyt c activates caspase 9 which in turn activates
caspase 3 and caspase 7, which execute apoptosis. The caspase-independent pathway
utilizes either the apoptosis inducing factor (AIF) which is released, or failure of the
electron transport chain. The AIF ultimately induces chromatin condensation and DNA
fragmentation.
In ischemia/reperfusion injury, there is evidence to support both pathways of
programmed cell death playing important roles in death of neurons.(Puka-Sundvall et al.
2000; Northington et al. 2001) Furthermore, it is the release of apoptogenic factors from
the mitochondria that seems to initiate the cell death paradigms.(Sanderson et al. 2008;
Hetz et al. 2005; Cao et al. 2007; Sugawara et al. 1999) Cells that die because of ischemic
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insults (specifically by delayed neuronal death pathways, not initial hypoxic insults) do so
in an energy-dependent manner: it requires the expression of new genes; is mediated by
the caspases; and employs the proteolytic mechanisms of apoptosis.(Dirnagl, Iadecola C
Fau - Moskowitz, and Moskowitz 1999; Lee, Zipfel, and Choi 1999; Lipton 1999;
MacManus and Linnik 1997; Schulz, Weller M Fau - Moskowitz, and Moskowitz 1999)
Ischemic neuronal death is initiated in an programmed manner, beginning first in the
mitochondria thus triggering cleavage of the caspases leading to destruction of key
cellular structures and irreversible fraying of the genome, thus leading some investigators
to term delayed neuronal death as regulated necrosis.
Fiskum et al. demonstrated that neuronal mitochondria are particularly sensitive to
energy depletion and respond in turn according to the duration of ischemia.(Fiskum 2000;
Fiskum, Murphy An Fau - Beal, and Beal 1999) Ouyang et al. found, by observing
mitochondria in experimental stroke, MTP opening within 1 hour of ischemia;(Ouyang et
al. 1999) furthermore, Friberg et al. showed that MPT opening corresponded to brain
areas most sensitive to ischemia.(Friberg et al. 1999)
Because the mitochondrial membrane permeability to cell death mediators
increase during ischemia, Fujimura et al. were able to demonstrate that parts of the
mitochondria, such as cytochrome c, enter the cytosol 4 hours after MCA
occlusion.(Fujimura et al. 1998) Because of these findings, it tempting to conclude that
cell death following ischemia occurs according to an apoptotic paradigm, though this is
not entirely accurate because similar phenotypes can be observed in necrosis as
well.(Hirsch et al. 2005) At the same time, DNA damage that is observed in brain
ischemia, while not necrotic, is different than what is seen in apoptosis.(MacManus and
Buchan 2000; MacManus and Linnik 1997) These results were further corroborated by
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Colbourne et al. who found no evidence of apoptosis in approximately 40,000 CA1
neurons that had undergone global ischemia.(Colbourne, Sutherland Gr Fau - Auer, and
Auer 1999) Furthermore, ischemic neurons differ morphologically from classical
apoptosis and thus their death cannot be explained by either classical necrosis, nor
apoptosis paradigms. (Deshpande et al. 1992; van Lookeren Campagne and Gill 1996;
Martin et al. 1998; Colbourne et al. 1999; Colbourne, Sutherland Gr Fau - Auer, and Auer
1999; Ishimaru et al. 1999)
A significant body of literature has looked at the Bcl-2 group of proteins that
modulate permeability to cytochrome c and thus delayed neuronal death cascades. Bax
and Bak seem to be the primary candidates that induce the release of cytochrome c but
also other pro apopototic proteins like AIF, Smac/Diablo.(Cheng et al. 2001; Kuwana and
Newmeyer 2003)
Thus, the question remains how neurons that are ischemic die. For MacManus et
al. a combination of necrosis and apoptosis might be the answer with necrosis at one end
of the spectrum and apoptosis on the other.(MacManus and Buchan 2000) These
correspond to attractor states that Lipton (Lipton 1999) and DeGracia have convincingly
argued is the most sensible way to approach neuronal death or survival.(DeGracia et al.
2017) McManus et al. argue that the attractor state, where an ischemic cell ends up is
dependent upon the severity of the ischemic insult, ATP availability, and both the age and
location of the neurons.(Dirnagl, Iadecola C Fau - Moskowitz, and Moskowitz 1999)
Therapies for Ischemia/Reperfusion Injury
Since free radicals have a deleterious effect on cells following reperfusion,
eliminating them during early reflow is a critical concern of therapy. Studies have shown
that following reflow, ROS production greatly surpasses any endogenous antioxidants.
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To address this issue, a series of clinical trials was undertaken and funded by
AstraZeneca in the early 2000s which looked at whether a known ROS trapping
compound, NXY-059, given intravenously following the administration of tPA, would show
the same neuroprotection in patients as it did in animal models. NXY-059 is a chemical
derivative of phenylbutylnitrone (PBN). The original Stroke-Acute Ischemic NXY
Treatment I (SAINTI) trial enrolled 1699 patients and administered either the compound
or placebo within 6 hours of stroke onset for a 72-hour infusion. The outcome measures
assigned were based on the modified Rankin scale which assesses the degree of stroke
disability on a 6 point scale – 0 being no symptoms and 6 corresponding to death. The
SAINT I trial found that administration of NXY-059 significantly reduced disability three
months after stroke, but did not improve other outcome measures. The authors concluded
that additional trials would need to be done.(Lees et al. 2006)
Soon thereafter the SAINT II trial was conducted which enrolled more patients
(3306). Like the SAINT I trial, NXY-059 was infused for 72 hours within 6 hours following
the beginning of stroke symptoms. The primary endpoints as before were disability scores
on the modified Rankin scale 90 days later and secondary endpoints were scores on
neurologic and activities of daily living scales. The SAINT II trial found no significant
difference between NXY-059 and placebo groups for either their primary or secondary
endpoints.(Shuaib et al. 2007) The authors of SAINT II argue that the false positive
observed in SAINT I likely occurred by chance, potentially because the first trial included
patients who went on to develop a poorer progression who were included in the placebo
group. In any case, intravenous ROS scavenging was shown to be ineffective to treat
reperfusion injury following acute ischemic stroke. It is likely that these studies failed for
several reasons: first, rapid delivery of a compound to the tissue is difficult, not only
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because of vascular occlusions, but also the ability to cross the blood brain barrier;
secondly the half-life of ROS is extremely short and by the time the compound diffuses
from the blood, across the plasma membrane, through the cytosol and into the
mitochondria, the ROS burst is likely over and the damage has been done. Thus, systemic
antioxidants have not been effective in targeting ROS mediated reperfusion injury. It is
for this reason that this study has sought, based on the previous work of the
Hüttemann/Sanderson labs, to limit ROS production rather than scavenge ROS. Here we
propose that direct targeting of the main mechanism of ROS generation – ΔΨm – can be
a promising, novel therapeutic strategy and has been shown to be itself protective. (Iijima
et al. 2006; Pandya, Pauly Jr Fau - Sullivan, and Sullivan 2009; Brennan et al. 2006)
Conclusions
This chapter has sought to present a working model for ischemia/reperfusion injury
based on the role of the mitochondria in generating ROS during early reflow. Our group
has demonstrated support for this model in previous works. We hypothesize that
mitochondrial membrane potential hyperpolarization is directly responsible for ROS
production, which in turn causes oxidative damage to the cell and initiates delayed
neuronal death pathways. We argue that ischemia leads to post-translational modification
of OxPhos complexes, primarily dephosphorylation, due to calcium-mediated activation
of endogenous phosphatases. This leads to a loss of allosteric regulation and priming of
ETC enzymes for hyperactivity and membrane hyperpolarization when the substrate, O2,
is restored during reperfusion. Because of the membrane potential hyperpolarization
when oxygen does return, ROS is quickly and exponentially generated by complexes I
and III which inundates any endogenous antioxidants, damages the cell, and activates
delayed-neuronal death cascades. Furthermore, ROS scavenging has been shown to be
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ineffective in targeting this ROS, likely due to the inability to deliver adequate doses to
sub-cellular compartments, in particular the mitochondria, quickly enough. However, our
model opens the door for the development of a novel therapeutic strategy that targets the
membrane potential itself thus eliminating the need for ROS scavenging and stopping its
production at its source.
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CHAPTER 2 - MITOCHONDRIAL MODULATION BY NEAR-INFRARED LIGHT IN
BRAIN ISCHEMIA
Introduction
Brain ischemia is a major cause of death and disability globally. As was outlined in
detail in Chapter 1, because neurons are both metabolically demanding, and rely almost
entirely on oxidative phosphorylation to meet these energy demands, any disruption in
the delivery system of oxygen and metabolites to brain tissue has dire consequences.
Blood flow can be disrupted to the brain in three primary pathologies. First, global brain
ischemia occurs when systemic arterial pressure falls below the ability of the brain’s
autoregulatory system to maintain adequate cerebral perfusion. This occurs most
commonly during cardiac arrest when cardiac output plummets and, since, it is systemic
pressure that falls, neither the usual anatomic nor physiological mechanisms can ensure
blood flow to the brain and thus the entire brain experiences ischemia. Brain regions that
are most susceptible to death following global brain ischemia are the CA1 region of the
hippocampus as well as areas that lie between the distal ends of two collateral vessels.
Known as watershed zones, these areas heavily rely on adequate perfusion pressure
through the collateral vessels to receive blood. Furthermore, it has been noted that brain
damage following cardiac arrest/resuscitation leading to global brain ischemia results in
three processes: 1) most structural damage is seen during the reperfusion phase and not
during the initial ischemia; 2) cortical pyramidal neurons in layers III and V and the CA1
and CA4 hippocampus are most sensitive and display what is known as “selective
vulnerability”; 3) during reperfusion, these selectively vulnerable neurons demonstrate a
sustained reduction to synthesize new proteins.(White et al. 1996) Like global brain
ischemia, several pathologies taking place following birth can induce brain ischemia in
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neonates resulting in neonatal hypoxic-ischemia encephalopathy. Finally, relevant to this
study, focal brain ischemia occurs when a limited region of the brain becomes ischemic
due to the occlusion of a blood vessel. In all three cases of brain ischemia, quickly
restoring blood supply is crucial for saving neurons and preventing further brain damage.
However, as was outlined in detail in Chapter 1, restoration of blood flow results in the
generation of mitochondrial ROS due to mitochondrial membrane hyperpolarization that
go on to further damage cells in a pathology known as reperfusion injury. Thus, to
effectively treat reperfusion injury, ROS must be reduced as quickly as possible. As we
described previously, pharmacological approaches have been unsuccessful in achieving
this goal.
These approaches for reducing ROS have largely been ineffective likely due to a
combination of factors including the inability of compounds to reach brain tissue via the
blood stream when an artery is occluded; as well as the difficulty in getting compounds
into sub cellular compartments fast enough following the initial ROS burst within the first
seconds to minutes following reperfusion. It has thus been the goal of our laboratory to
develop a non-invasive therapy that can be applied immediately upon reflow and reduce
the amount of ROS produced rather than scavenging them. Our approach has been to
use infrared light (NIR) which, unlike other wavelengths of the visible light spectrum can
easily penetrate tissues within a range of 700-1000 nm and thus can target deep cellular
structures.
Modulating Mitochondrial Activity Using Near Infrared Light
Near-infrared light has been shown to be beneficial and to influence the
mitochondria(Yu 1997; Yeager 2005; Wong-Riley et al. 2005; Streeter 2004; Eells 2004,
2003; Wong-Riley 2001). Furthermore, it has shown promise in regenerating nerves,
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stroke, peripheral neuropathy and wound healing.(Wong-Riley et al. 2005; Whelan 2003;
Leonard 2004; Bae 2004; DeLellis 2005; Lim 2009; Lapchak 2007; Oron 2006;
Detaboada 2006; Lapchak 2004) However, results have been inconsistent at best. The
contradictory nature of the results is likely due to a limited understanding of how NIR
exerts its action upon cell function.
Cytochrome c oxidase (CcO) is the terminal enzyme in the electron transport chain
and the proposed rate limiting step of the entire reaction. The dimeric enzyme is
comprised of 13 subunits per monomer and is regulated, as we previously described, by
post translational phosphorylations, and the ATP/ADP ratio which in healthy cells adjusts
energy production to energy demand. It is widely accepted that CcO is the primary
photoreceptor of NIR. The enzyme is composed of chromophores that include two copper
centers that are involved in enzymatic action and have been shown in previous studies
to be the sites of photoreception of NIR.(Karu 1999; Karu and Afanas'eva 1995; Mason
2014) Copper broadly absorbs light in the near NIR range of wavelengths (700 to 1000
nM).(Hazeki O 1988; Griffiths DE 1961; Wharton DC 1964) The Hüttemann lab used
N,N,N’,N’-tetramethyl-p-phenylenediamine (TMPD) which is an electron transport
catalyst that alters the phase of CcO kinetics from biphasic to monophasic in order to gain
mechanistic knowledge of how NIR affects CcO. Unlike in vivo where cytochrome c
associates and dissociates from CcO, in the presence of TMPD, cytochrome c stays
bound to CcO while the compound itself shuttles electrons to cytochrome c from
ascorbate which is a reductant thus eliminating the need for cytochrome c to bind and
then dissociate from CcO. It was found that in the presence of TMPD, the inhibitory effect
of NIR is significantly reduced and thus it is hypothesized that the inhibitory wavelengths
affect the binding of CcO with cytochrome c at the CuA center of CcO next to the
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cytochrome c binding site. Despite these insights, detailed understanding of the
mechanism of how NIR can modulate the activity of CcO is not yet fully understood.
Many studies have shown that NIR can activate CcO.(Wong-Riley 2001; WongRiley et al. 2005; Yu 1997; Yeager 2005; Streeter 2004; Eells 2004, 2003) For example,
applying wavelengths of 670 nm and 808 nm increased CcO activity and in turn overall
mitochondrial respiration,(Wong-Riley et al. 2005; Pastore, Greco, and Passarella 2000)
and the Hüttemann lab has shown that this holds true for one wavelength (810 nm). This
was tested on isolated CcO enzyme from cow liver and pig brain (unpublished), in which
four wavelengths were discovered that show CcO inhibition for the first time after
scanning the near NIR range between 700-1000 nm: 750, 870, 910, 950 nm.(Sanderson
et al. 2018) This range was chosen because it is classically considered the “therapeutic
window of opportunity” because NIR absorbance by other biological compounds like
blood and water are minimal. Using a light-protected oxygen electrode chamber that was
combined with a double beam spectrophotometer, isolated and purified CcO was
subjected to the wavelengths of NIR and its activity measured. It was later shown that
CcO activity can also be optimally inhibited by two wavelengths of NIR, specifically 750
nm or 950 nm, and this effect is compounded when the wavelengths are
combined.(Sanderson et al. 2018)
Next, the Hüttemann/Sanderson laboratories isolated mitochondria in order to
measure the effect of NIR on mitochondrial respiration.(Sanderson et al. 2018) It was
found that applying the inhibitory wavelengths reduced respiration by 24-25% while the
excitatory 810 nm wavelength increased respiration and thus overall oxygen
consumption. When the inhibitory wavelengths were combined (750 + 950 nm),
respiration was reduced by 34 %.

29
NIR Proposed Mechanism in Reducing ROS
As was described in chapter 1, the ETC transfers electrons to oxygen, a reaction
that is the rate limiting step(Villani 1997; Kunz 2000; Acin-Perez 2003; Piccoli 2006;
Dalmonte 2009), catalyzed by cytochrome c and CcO. As electrons pass through
complexes I, III, and IV, protons are simultaneously pumped across the inner
mitochondrial membrane, into the intermembrane space. The action of transferring these
protons generates the mitochondrial membrane potential (ΔΨm) which is a measure of
the difference in electrical potential across the membrane. Moreover, as described in
detail in Chapter 1, reperfusion hyperpolarizes the membrane, increasing ΔΨm, and
inducing an exponential increase in ROS production. Therefore, it stands to reason that
any action enacted on the rate limiting step, cytochrome c/CcO, can either speed up or
slow down the entire reaction. Moreover, direct modulation of CcO with NIR, may allow
for controlling ΔΨm and thus ROS production.
To interrogate this hypothesis, the Sanderson laboratory used live-cell imaging
with the ΔΨm fluorescent probe, TMRM.(Sanderson et al. 2018) They found that
irradiating the cells with NIR with the 950-nm wavelength, decreased the membrane
potential which rapidly returned to basal levels when the light was no longer applied. Next,
NIR was tested in an in vitro model of ischemia reperfusion injury. Using immortalized
hippocampal cells (HT22 neurons), it was discovered that the mitochondrial membrane
potential is indeed hyperpolarized during the first 30 minutes following reperfusion.
Moreover, irradiation of the cells with the inhibitory NIR reduced the membrane potential.
Next, the group examined the survivability of neurons that were given NIR
treatment following oxygen-glucose deprivation.(Sanderson et al. 2018) Cells received
NIR treatment via fiber-optic light guides for an hour following reoxygenation and the
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number of cells that died were quantified using a Live/Dead viability assay 24 hours later.
Fewer cells died when treated with inhibitory NIR wavelengths (750 nm and 950 nm). In
contrast the excitatory wavelength of (810 nm) did not save cells.
NIR Reduced ROS Production in CA1 Hippocampal Neurons Following Reperfusion
Next

it

was

necessary

to

show

that

CcO

is

hyperactive

following

ischemia.(Sanderson et al. 2018) To interrogate this hypothesis, brains were harvested
after 8 minutes of global ischemia followed by reperfusion. CcO specific activity was
measured and a significant increase in activity was observed in brain tissue during
ischemia and reperfusion compared to non-ischemic controls. It is hypothesized that
these changes cause membrane hyperpolarization in vivo as shown previously.(Liu,
Fiskum G Fau - Schubert, and Schubert 2002) In order to confirm this theory, ROS
production was quantified using MitoSOX fluorescence, which detects mitochondrial
superoxide production. Following 8 minutes of brain ischemia and 30 minutes of reflow,
a seven-fold increase in MitoSOX fluorescence was observed in CA1 hippocampus,
indicating an accretion of ROS in these neurons. Consistent with our hypothesis,
irradiation with CcO-inhibitory NIR showed MitoSOX fluorescence similar to the shamsurgery control groups, suggesting that CcO-inhibitory NIR treatment can prevent ROS
formation.
NIR Therapy Given at the Onset of Reperfusion Reduces CA1 Hippocampal
Neuronal Death Following Global Brain Ischemia/Reperfusion
The first in vivo study of the neuroprotective efficacy of NIR was performed in the
rat

global

ischemia

model

following

bilateral

carotid

occlusion

with

hypotension.(Sanderson et al. 2013) As described above, neuronal death occurs
predominantly in the CA1 hippocampus in this model. These neurons are particularly

31
sensitive to this insult and a near total loss of CA1 hippocampal neurons can be seen 37 days following reperfusion. In our study, untreated controls showed a significant loss of
CA1 hippocampal neurons after 14 days (88%) as measured by cresyl violet staining and
neuN fluorescent neuronal markers. Furthermore, gliosis was seen, characterized by
immune

responses;

particularly

inflammatory

cells

entering

the

area.

Ischemia/reperfusion injury induced the translocation of microglia and macrophages as
well as astrocytes, all seen in the CA1 hippocampus using confocal microscopy.
Animals treated with CcO-inhibitory wavelengths of 750nm and 950 nm, either
alone or combined, showed significant reductions in hippocampal neuronal death.
Animals treated with the NIR inhibitory wavelengths only had 11 to 35 % of their CA1
hippocampal neurons die. As predicted, the CcO-excitatory wavelength of 810 nm did not
improve the survivability of these neuron populations.(Sanderson et al. 2018)
NIR Therapy Reduces Brain Injury in Neonates Following Simulated Hypoxia
Approximately 0.002-0.004% of at-term hospital births result in the neonatal brain
becoming hypoxic which leads to a condition known as hypoxic-ischemic encephalopathy
(HIE). This pathology can cause long-term health issues such as cerebral palsy or
epilepsy.(Al-Macki 2009) A number of factors can contribute to HIE such as maternal
hypotension; however, the most common cause is compression of the umbilical cord or
prolapse and placental abruption. Moreover, neonatal brains are also susceptible to
reperfusion injury. Unpublished work from our laboratory has shown that in the VinucciRice model of HIE, the inhibitory NIR wavelength of 750 nm reduced brain injury due to
hypoxia-ischemia in neonates – a finding that is consistent with the global ischemia
model. Moreover, inhibitory NIR applied at the onset of reperfusion reduced caspace-3
cleavage thus stopping cells from undergoing programmed cell death.(Reynolds 2015)
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Conclusion
Both the published and unpublished data from the Hüttemann/Sanderson
laboratories provide evidence for our model of IR injury in which transient reductions in
mitochondrial membrane potential during reperfusion can reduce ROS production, which
is the number one cause of neuronal death in IR injury. (Mason 2014; Hazeki O 1988) As
was described in chapter 1, the relationship between ROS and ΔΨm is exponential – when
the membrane potential exceeds 140 mV due to hyperactivation of the complexes, ROS
increases exponentially. We thus argue that even moderate reductions in membrane
potential can enact an exponential decreases in ROS production. This was first shown in
HT22 cells in which we showed that inhibitory NIR reduces CcO activity. When the same
wavelengths were applied immediately upon reperfusion in an in vivo rat model of global
brain ischemia, we saw significant reductions in CA1 hippocampus neuronal death which
was corroborated by behavioral improvements as measured by memory and spatial
learning tasks. Moreover, similar results were seen in a neonatal model of brain
ischemia/reperfusion. Thus, in two animal models, NIR has been shown to reduce ROS
production in early reperfusion by directly targeting the rate limiting enzyme of the ETC,
CcO, reducing its activity and thus reducing overall ΔΨm.
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CHAPTER 3 - MAGNETIC RESONANCE IMAGING IN STROKE RESEARCH AND
IAGNOSIS
MRI Fundamentals
A series of elegant experiments in 1938 by Isidor Rabi first performed in gas beams
revealed a unique principle of matter: magnetic resonance.(Rabi et al. 1938) In 1973,
Paul Lauterbur published the first magnetic resonance image in Nature.(Lauterbur 1973)
He placed two 1-mm tubes of water in a 1.4 T magnet and when he applied magnetic
field gradients rotating by 45 degrees, he was able to produce four, one-dimensional
projections of the signal. When working backwards, these images were then able to
produce a 2-dimmensional image.
Physiologically, water is the most abundant compound in the brain followed next
by lipids, both of which are heavily comprised of protons which can generate an MRI
signal and they have a mass, a charge (positive), and a spin. Spin, in the case of
subatomic particles, is an intrinsic component of the proton, which means that it is
independent of any external force, causing the particle to spin like a top along an axis
with a wobble. Furthermore, spin on an individual proton is ½ Plank’s constant. Thus, the
combination of the charge and spin means that protons have a nuclear magnetic moment,
which is defined as a nonzero magnetic dipole. Thus, protons rotating on an axis generate
a small magnetic field. However, it must be noted that at room temperature they are
randomly oriented with their spins being either -1/2 or +1/2 and as a result, there is no net
magnetization – body tissues, for example, are not magnetic.
If a tangential force is applied along the z-axis the proton wobble increases. This
force, in MRI, is generated by a radio-frequency (RF-pulse) which is time-dependent
sinusoidal wave that matches the precessional, or Larmor frequency of the protons. It is
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critical that the RF pulse matches the Larmor frequency because the key is to generate
resonance strong enough to push the protons into the transverse rotational plane.
Applying an RF pulse at a proton’s Larmor frequency causes its net magnetization (M) to
flip and rotate into the transverse magnetization. Due to Faraday’s law of electromagnetic
induction, any magnetic field can interact with an electric circuit to produce an
electromotive force. Thus, as protons begin rotating in the transverse plane due to their
spins being flipped 90 degrees by the RF pulse, they induce a current each time they spin
through the copper receiving coil. Thus, the current signal that is produced encodes the
Larmor frequency. Since the protons composing different tissues, fat, bone, muscle, etc.
have different precessional frequencies due to the atomic composition of the tissue itself,
frequency encoding can differentiate the tissues based on the RF pulse applied.
MRI in Stroke
Brain imaging in cases of acute stroke provides critical information to clinicians
regarding stroke severity and location in a timely manner, thus allowing physicians to
quickly determine whether the patient is a candidate for receiving fibrinolytic therapy. Prior
to initiating this treatment, other pathologies such has cerebral hemorrhage must be ruled
out. To date, computed tomography (CT) imaging is still the best approach for
differentiating hemorrhagic from ischemic stroke. However, due to the requirement for
systemic administration of a radioactive contrast agent, as well as low sensitivity in
detecting ischemic lesions, it remains suboptimal. Many studies since the early 1990’s
have provided convincing evidence that MRI is a far superior imaging modality for use in
diagnosis of acute ischemic stroke.(Baird and Warach 1988; Barber et al. 1998;
Schellinger et al. 2001; Tong et al. 1998) In what follows we shall review in greater detail
the most common and useful MRI modalities both in the clinic and in the utilization in this
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study.
Diffusion Weighted Imaging (DWI)
In 1905, Albert Einstein published a paper in which he refined the theory of the
Scottish-born botanist, Robert Brown to describe the apparent movement of molecules
suspended in a liquid due to the molecular-kinetic theory of heat.(Einstein 1905) If a drop
of ink were to be added to a beaker of water, the ink atoms would diffuse throughout the
beaker seemingly, though, because the diffusion is unimpeded, the probability of finding
any particle of ink, according to Einstein, can be predicted using a diffusion coefficient
that is related to the mean square displacement of the Brownian particle, where, the mean
square displacement reflects the derivation of the particle’s position with respect to a
certain position over a given period of time.(Michalet 2010) Thus, diffusion maps can be
generated in Euclidean space comprised of a set of coordinates that were determined
from the eigenvalues and eigenvectors of the diffusion constant.(Coifman and Lafon
2006; Coifman et al. 2005)
Within most fluids diffusion is even, as we saw in the example of the ink in the
water, which results in equal diffusion of particles in all directions across time. This is
called isotropic diffusion and defined with a single diffusion coefficient. Biological tissues,
however, present a myriad of impediments to free diffusion and thus result in a number
of diffusion coefficients in multiple directions. This behavior is known as anisotropy, where
diffusion must be described by a 3 x 3 matrix known as the diffusion tensor. The nervous
system in particular is highly anisotropic due to the presence of cell membranes and
myelination, both of which are highly hydrophobic and thus impede the free diffusion of
water.(Beaulieu 2002)
During brain ischemia, cessation of blood flow has a direct effect on the ionic
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gradients. Hossmann et al. performed a key set of experiments in which they recorded
the activity of extracellular sodium and subarachnoid sodium ions using ion-sensitive
electrodes. During ischemia, they found extracellular [K+] increases from 3.3 to 56 mEq
per liter and [Na+] decreases from 133 to 53 mEq per liter. Following reperfusion, ionic
distribution gradually returned to physiological levels within an hour. Most notably, they
found that the intracellular uptake of sodium was accompanied by a water shift into the
intracellular compartment which resulted in shrinking of the extracellular space from 18.9
to 8.5 vol%.(Hossmann Ka Fau - Sakaki, Sakaki S Fau - Zimmerman, and Zimmerman
1977) Because acute stroke leads to rapid reductions in the OxPhos capabilities of the
cell, ATP stores plummet and lactic acid accumulation increases which leads to failure of
the Na+/K+-ATPase. As Hossmann found, pump failure causes ions to equilibrate across
the neuronal membrane following their concentration gradients. This in turn leads to a
shift of fluid into the cell. Furthermore, these processes occur in a matter of minutes
following ischemia.(Hossmann Ka Fau - Sakaki, Sakaki S Fau - Zimmerman, and
Zimmerman 1977; Moseley, Kucharczyk J Fau - Mintorovitch, et al. 1990) The reduction
of the extracellular space by about 55% increases the anisotropy of ischemic brain tissue
thus trapping water molecules between membranes that were previously free to diffuse
along membranes. Using strong magnetic field gradient strengths (b values of 1413
s/mm2), Moseley et al. found that, in MCA occluded cats, DWI signal strength showed a
significant hyperintensity following 45 minutes of ischemia that was not seen in other
imaging modalities such as T2 weighted imaging (T2WI).(Moseley, Cohen Y Fau Mintorovitch, et al. 1990) Thus, as water becomes more impeded during ischemia, DWI
signal intensity increases.
However, the question then arises, does DWI show actual cell death or just
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edema? Sodium ion influx into the cell following ATP reduction also leads to chloride influx
through the chloride channels leading to an increase in osmolality that favors water to
shift inward through the aquaporin channels.(Badaut et al. 2001; Badaut et al. 2002;
Kimelberg 2004; Moseley, Cohen Y Fau - Mintorovitch, et al. 1990) As the intracellular
fluid volume increases and the extracellular space decreases, alterations form in
membrane architecture resulting in blebbing. Thus, when the ionic pumps fail, the cell
dies via a process known as oncosis,(Weerasinghe and Buja 2012) first coined by von
Recklinghausen.(Szabo 2008) Furthermore, oncotic death can be morphologically
characterized by damage to membrane phospholemma and organelle membranes, as
well as loss of phospholipids and the eventual disappearance of nuclei.(Barros, Castro J
Fau - Bittner, and Bittner 2002; Barros, Hermosilla T Fau - Castro, and Castro 2001;
Majno and Joris 1995) Thus, cellular edema in brain is definitively cytotoxic and therefore
a positive DWI signal indicates very early on the extent of neuronal infarction plus
edema.(Liang et al. 2007) It is important to clarify that the early time point shows edema
in addition to ischemic cell death because infarct sizes become smaller when measured
by T2 weighted imaging during the chronic phase of stroke.
The quantification of impedance of water is known as the apparent diffusion
coefficient (ADC), which is calculated by software and reflects the degree of diffusion of
water within the tissue under examination.(Schlaug et al. 1997) The higher the ADC
value, the more freely water diffuses and therefore the brighter the area on the image. An
ischemic lesion that has restricted diffusion of water due to the death of cells will have a
lower ADC and thus appear hypointense.(Baird and Warach 1998)
In addition to the ADC, another important variable in DWI is the b value. The bvalue is a measure of the strength and duration of the field gradients: the higher the b
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value, the more powerful the diffusion weighting and thus the more accurate the imaging
of diffusion effects.(Stejskal and Tanner 1965; Kingsley and Monahan 2004; Burdette et
al. 2001) In this modality, acute stroke appears hyperintense to surrounding tissue.
In conclusion, though initially shown in animal models that DWI can become
positive as early as 5 minutes into ischemia, this occurs 2 to 6 hours after the onset of
symptoms in humans. (Reith et al. 1995; Back et al. 1994; Sevick et al. 1992; PerezTrepichio et al. 1995; Marks et al. 1996; Sorensen et al. 1996; Warach, Dashe Jf Fau Edelman, and Edelman 1996) The ability to detect lesions is certainly an advantage of
DWI but it is not the only one: other assets to the technique include low false negative
rates (5%)(Singer et al. 1998) and it is also able to clearly delineate between ischemic
and non-ischemic parenchyma(Lutsep et al. 2004; Marks et al. 1996; Koroshetz Wj Fau
- Gonzalez and Gonzalez 1997), and the ability to differentiate acute and chronic ischemic
zones.(Lutsep et al. 2004; Singer et al. 1998) Thus, it has been shown clinically that DWI
is far superior to other imaging modalities in detecting early strokes and shows a high
correlation between stroke lesion volume and clinical outcome. (van Everdingen et al.
1998)
T2-Weighted Imaging
T2 weighted imaging relies on the transverse relaxation, also known as “spin-spin”
relaxation of the magnetization vector. Once the RF pulse inverts the proton spins, they
begin to relax away from the transverse plane to the longitudinal one. While this is
happening, the spins deteriorate from their position in the transverse plane and the
amount of time of decay reflects the T2. The amount of time it takes for each proton to
undergo T2 decay depends on inherent properties of the tissues but also its magnetic
susceptibility.
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The T2 sequence is comprised of the following imaging characteristics that equip
the modality for imagining of the brain in both its physiological and pathological states.
The T2 signal increases (appears brighter) when there is greater water content, such as
in cases of edema, tumors, infarction, and infections. Blood also appears bright as does
cerebral spinal fluid (CSF). The reason why these compounds appear brighter is because
they have a longer transverse relaxation time, or a faster relaxation time. In pure water,
the T2 is very long, on the order of 3-4 seconds because unimpeded water moves faster
than the Larmor frequency. As protons become more constrained in larger molecules, the
relaxation time shortens because the motion of the protons slows down. A shorter
relaxation time means that the protons stay for a shorter amount of time in the transverse
plane before returning to their net magnetization position and thus produce a darker
image. As the amount of water in a tissue decreases, such as in cases of bone or soft
tissue, the signal is lost more quickly and the image appears darker in those areas. (AllisyRoberts and Williams 2008; Mitchell Dg Fau - Burk et al. 1987)
In stroke, T2 lesions appear as bright, hyperintense regions that become positive
in humans within the first 3-8 hours after the onset of ischemia.(Mohr et al. 1995) N van
Bruggen et al. found that, consistent with previous findings, cerebral edema is accurately
identified by T2WI which they corroborated histologically by tracing the localization of a
tracer protein. (van Bruggen et al. 1992) Interestingly, there is a lag time before T2
becomes positive, with T2 becoming positive more chronically and DWI more acutely.(van
Bruggen et al. 1992) For this reason, both imaging modalities are commonly used
clinically: DWI very early in the course of stroke to identify lesions quickly, and T2WI to
track chronic lesions.(Powers et al. 2018)
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Perfusion Weighted Imaging
Measuring cerebral perfusion both during ischemia and reperfusion provides
important information on the extent of tissue that is at risk for infarction in the absence of
intervention. Tracking the movement of blood through the brain’s vasculature can be
accomplished by several imaging modalities, most notably CT angiography (Knauth et al.
1997; Shrier et al. 1997) and gadolinium based MRI.(Merten et al. 1999) In what follows,
arterial spin labeling (ASL) MRI will be discussed as a viable alternative to both these
techniques.
Arterial Spin Labeling Perfusion MRI (ASL)
Arterial spin labeling is an MRI modality that uses arterial blood as an endogenous
contrast to measure perfusion thus eliminating the need for injecting contrast agents or
tracers.(Alsop and Detre 1995; Buxton et al. 1998; Rosen et al. 1990; Detre et al. 1994;
Wolf and Detre 2007; Petersen et al. 2006; Alsop and Detre 1998; Williams et al. 1992;
MacIntosh et al. 2010; Liu and Brown 2007; Wong et al. 2006; Golay, Hendrikse J Fau Lim, and Lim 2004; Wu et al. 2007; Zhang et al. 1995; Barbier, Lamalle L Fau - Decorps,
and Decorps 2001; Detre et al. 1992) The technique works as follows: first, the computer
obtains control images of an area of interest. Following this, radio frequency pulses are
applied to an area that is upstream from the region of interest that invert the magnetization
of the protons composing water within this slab (usually in the neck). These inverted
protons which are magnetically labeled can flow into the region of interest where they mix
and displace their magnetization to the unlabeled water thus slightly reducing the
equilibrium magnetization in the region of interest. The region of interest is imaged once
more and the tagged images are subtracted from the control images. Because the labeled
water molecules freely cross from capillaries into extracellular space and even enter cells,
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perfusion rates can be calculated.
ASL can be further subdivided into continuous ASL (CASL) and pulsed ASL
(PASL). CASL, first proposed by Williams et al. in 1992,(Williams et al. 1992) involves
continuous radiofrequency labeling through a narrow slice of the neck. Magnetization is
inverted by the dual application of a continuous pulsed RF for two to four seconds and a
magnetic field gradient oriented in the direction of blood flow.(Ferré et al. 2013) An
advantage of using CASL is that it has higher contrast.(Wang et al. 2002) However,
notable disadvantages are the high magnetization transfer (MT) and the high level of
energy that is applied to the tissue.(Ferré et al. 2013)
PASL, in contrast uses very short RF pulses over larger areas.(Ferré et al. 2013)
Symmetrical PASL uses the flow alternating inversion recovery (FAIR) method in which
a non-descript pulse that inverts the protons is applied during the control phase that
eventually becomes selective when a slice-selection gradient is applied during the
labeling phase.(Kim 1995) The asymmetrical methods, which are the ones employed in
this study, involve what was described above: a labeling zone with a 10-15 mm thickness
that is located away from the region of interest that is subtracted from a control image.
(Edelman et al. 1994)
The goal of perfusion imaging in the context of acute stroke is to identify
hypoperfused tissue (penumbra) and to differentiate it from the ischemic core.(Parsons
et al. 2010; Bivard et al. 2011) The usefulness of perfusion weighted imaging lies in both
its ability to track cerebral blood flow within a specific volume of tissue per unit time and
thus an ischemic threshold can be set; but also, volumetric analysis can be performed on
gross tissue to determine the ratio between at-risk and infarcted tissue – this is known as
the perfusion/diffusion mismatch and will be outlined in greater detail below.
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Perfusion/Diffusion Mismatch
Identifying tissue that has the potential to be salvaged by conventional stroke
therapies is paramount in the clinical setting. Ischemic stroke zones, as we have
previously seen, can be broadly defined as core and penumbra. The core is classically
defined as the area of brain most proximal to the occluded vessel containing neurons that
rapidly undergo energy depletion, anoxic depolarization and death following a necrosis
morphology; unfortunately, nothing can be done to salvage these neurons. Surrounding
the ischemic core is an area of brain that receives enough blood flow from collateral
vessels that maintains neuronal viability even in the absence of their electrical activity.
This area has been termed the penumbra and if left untreated eventually goes on to die
via a delayed neuronal death program. Thus, restoration of blood flow through tPA or
thrombectomy in a timely manner is of critical importance to save penumbral neurons.
However, as we previously described, the very same intervention designed to save them
can result in their downfall following reperfusion; though ROS is only one component of
the injury mechanism.
Since the ischemic brain is not homogenous but is comprised of different zones of
viability and activity according to collateral flow rates, it stands to reason that they can be
imaged, in vivo, and conclusions drawn regarding the extent of the ischemia as well as
the potential for saving the penumbra.
In any given area of ischemic brain, PWI hypointensities can be defined as an area
that is at risk for infarction and DWI hyperintensity as already infarcted tissue. It was thus
theorized that a volume for volume mismatch exists between at-risk and infarcted tissue
or PWI and DWI on MRI modalities during the early phase of ischemia – a mismatch that
eventually grows smaller as the infarcted area grows larger over time due to either lack
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of intervention or reperfusion injury. Thus, the difference between PWI and DWI during
ischemia reflects potentially salvageable brain tissue. Some of the most compelling data
to the validity of the mismatch are that eventually diffusion abnormalities grow into the atrisk area. For example, in clinical studies that enrolled patients in neuroprotective
therapies it was shown that lesions on average grow from 144% to 180% from their initial
volume across time. Patients who were reperfused within clinically relevant time windows
had diffusion abnormalities stop growing which may suggest that the mismatch area was
salvaged. This was shown convincingly by Jansen et al.(Jansen O Fau - Schellinger et
al. 1999) Further corroborating these results, Parsons found that tPA treated patients had
higher mismatches than untreated controls – a finding which suggests that more at-risk
tissue was salvaged due to reperfusion.(Parsons et al. 2002) Interestingly, the PWI/DWI
mismatch may occur in patients as late as 24 hours and even later from the onset of
symptoms. Darby et al showed that while mismatch decreased across time, around 6070% of patients still had significant mismatches as late as 24 hours. (Darby et al. 1999)
It must be noted, however, that the PWI/DWI mismatch, at least according to
Kidwell et al, is based on two fundamental assumptions. First, the boundary of PWI
hypointensity that is seen delineates between the penumbra and healthy tissue. Second,
the boundary between PWI and DWI regions reflects the core. In what follows,
shortcomings of the PWI/DWI mismatch will be described in greater detail.
The primary criticism of this theory is that it is not easy to differentiate between true
penumbra and benign oligemia. The initial Astrups study found that rather than two clearly
defined regions of core and penumbra, there is an additional, third zone in which blood
flow falls below physiological levels but the tissue is at no time at risk for infarction.
Astrups defined these regions according to the amount of blood flow received per 100
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grams of tissue per minute. Core flow rates fell between 6 and 10 ml/100g/min. Penumbra
values fall between 10 and 20 ml/100g/min. While this criticism is valid, it still does not
explain how infarction volumes eventually expand into the at-risk volume if left untreated.
Conclusions
Multi-modal MRI has developed into the gold standard for stroke diagnosis and
treatment in the clinic. The ability to image the brain in real-time across a number of
parameters can give clinicians up to date information on the extent of brain injury as well
as the amount of tissue that can be salvaged by any therapeutic intervention. Perfusionweighted MRI is a powerful tool that gives insight on both relative cerebral perfusion rates
within a voxel of tissue or across slices, as well as the volume of hypoperfused tissue.
Diffusion weighted imaging can give an early assessment of infarcted brain tissue as well
as be a powerful predictor of final infarct size which can be computed in the chronic phase
of stroke by T2 weighed imaging. This project has employed all of these MRI modalities
in order to increase the translatability of our findings, as well as to track real-time, in vivo
changes in infarct progression in individual animals.
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CHAPTER 4 - INFRARED LIGHT THERAPY AS A NOVEL TREATMENT FOR
STROKE: TWO TREATMENT WINDOWS
Introduction
Stroke is one of the leading causes of death and disability in the Western world
and accounts for approximately 1 in 20 deaths in the United States.(Benjamin et al. 2017)
Ischemic stroke occurs due to the occlusion of an intracranial artery resulting in rapid and
cytotoxic reductions in blood flow to the brain parenchyma. Classically, neurons directly
affected by the occlusion have been divided into two groups: the ischemic core and the
penumbra. The core contains neurons that are closest to the occlusion which suffer rapid
energy depletion, ionic equilibration, and irreversible necrosis. Surrounding the core is
the penumbra which is a region that has increasing rates of perfusion moving outwards
because it is fed by collateral vessels, and as such remains ischemic yet viable.
Therefore, stroke therapies aim at reducing the size of the core and salvaging the
penumbra. Moreover, MRI modalities are becoming the gold standard for identifying
potentially salvageable brain tissue.
To date, the only approved treatment is rapid restoration of blood flow either
pharmacologically with tPA or surgically with a thrombectomy. While patient outcomes
have greatly improved due to these early interventions, a substantial amount of tissue
damage occurs during the reperfusion phase. As the ischemic brain tissue is reoxygenated, ROS are quickly generated, beginning at the early stages of reflow which
goes on to cause further cell death by way of complex, interacting molecular pathways. It
is important to note, however, that ROS are only part of the story. The inflammatory
response must also be considered. Nonetheless ROS play a key role and to date,
pharmacological treatment targeting ROS has thus far proven ineffective likely due to the
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inability to deliver effective concentrations of the drug to sub-cellular targets at the critical
stages of ROS generation during early reperfusion.
Mitochondria are the primary source of post-ischemic ROS generation. ETC hyperactivation due to changes (i.e., primarily loss) of post-translational modifications during
ischemia promotes hyperpolarization of the mitochondrial membrane potential at the
early phase of reoxygenation after ischemia and thus an exponential increase in
mitochondrial ROS production. Thus a treatment needs to be found that targets
mitochondria to limit reperfusion injury.
A series of studies looking at systemic hypothermia or mild hypothermia showed
promise in reducing brain injury following cardiac arrest in the dog model. (Leonov, Sterz
F Fau - Safar, Safar P Fau - Radovsky, and Radovsky 1990; Leonov, Sterz F Fau - Safar,
Safar P Fau - Radovsky, Radovsky A Fau - Oku, et al. 1990; Sterz et al. 1991; Weinrauch
et al. 1992; Kuboyama et al. 1993; Safar et al. 1996) In patients, therapeutic hypothermia
was first shown to be effective in a seminal study in the late 1950’s which reduced
mortality following global brain ischemia in patients who had suffered from cardiac
arrest.(Benson Dw Fau - Williams et al. 1959) Furthermore, two large clinical trials in
recent years have shown the therapeutic benefit of hypothermia following cardiac
arrest.(Bernard et al. 2002; 'Mild therapeutic hypothermia to improve the neurologic
outcome after cardiac arrest' 2002) Several groups have reported that in MCA occluded
rats hypothermia applied for as late as 3 hours following reperfusion could significantly
reduce infarct volume up to 50%-90%.(Huh et al. 2009; Maier et al. 2001) The Cooling
for Acute Ischemic Brain Damage (COOL AID) clinical trial showed some promise using
endovascular cooling in acute ischemic stroke but concluded that more studies were
needed.(De Georgia et al. 2004) Moreover, animal models of ischemia/reperfusion injury

47
have shown that hypothermia could reduce ROS production as well as improve
mitochondrial function in the heart and the brain.(Gong et al. 2012; Tissier et al. 2013)
Therapeutic hypothermia decreases cerebral metabolic rate by 6-7% for every 1 degree
decrease in body temperature, which in turn reduces oxygen demand of the brain.
(Polderman 2009; Erecinska, Thoresen M Fau - Silver, and Silver 2003) Results from
groups studying energy metabolism found that in rats that had undergone a normothermic
ischemic insult for 30 minutes and a 2 hour recovery (reperfusion) at 30° C had no
decrease in the activity of mitochondrial complexes II-III and IV. On the other hand,
decreases of 15-30% were seen in animals that had recovered at physiological
temperature of 37° C.(Canevari et al. 1999) Taylor et al. (2002) conducted studies in
which they looked at 6-hour whole body cooling to 30° C after three hours of normothermic
brain hypoxia-ischemia in 7 day old rat pups.(Taylor et al. 2002) When the pups were
sacrificed at 14 days, the PCr/Cr ratios were identical to control animals which indicated
neural protection. Thus, mild, short-term hypothermia seems to normalize cerebral
metabolic rate and reduce mitochondrial damage while increasing the duration of
hypothermia can reduce secondary changes to energetics, including both mitochondria
but also the immune response and thus salvage brain tissue.(Erecinska, Thoresen M Fau
- Silver, and Silver 2003)
As discussed in Chapter 2, previous studies from our group and others have
uncovered a novel property of the terminal enzyme in the mitochondrial ETC, cytochrome
c oxidase (CcO). It was found that this enzyme has photoreceptive properties that allow
CcO activity to be regulated by specific wavelengths of near infrared light (NIR). Previous
studies demonstrated that CcO activity can be stimulated by applying NIR wavelengths
of 670 nm and 808 nm, thus increasing mitochondrial respiration. The CcO multi-protein
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complex has several chromophores involved in enzyme catalysis. It is well-accepted that
the primary cellular photoreceptor for NIR are the catalytic copper centers of CcO, with a
broad absorbance spectra covering the NIR range of 700-1000nm.
Based on our model, however, increasing CcO activity during reperfusion would
be counterproductive since ETC complexes are already hyperactive due to changes in
their post-translational modifications leading to exponential ROS production during early
reperfusion. Our group has found that CcO activity can be reduced by applying inhibitory
NIR wavelengths (750 nm and 950 nm and the combination). Reduction of CcO activity
by inhibitory NIR leads to transient, reversible reductions in both mitochondrial respiration,
and the mitochondrial membrane potential. This in turn would lead to a reduction in the
amount of superoxide produced, thus salvaging neurons, a finding that our lab showed in
cell culture following oxygen glucose deprivation. Moreover, in addition to cell culture
models, we have shown profound neuroprotection of NIR in vivo in the rat model of global
brain ischemia in which we saw up to 89% of CA1 hippocampal neurons salvaged due to
NIR irradiation applied during reperfusion compared to 14% of surviving neurons in the
controls. While these results have been promising, further questions remain regarding its
applicability to a focal brain injury like acute ischemic stroke, which differs in the
pathological evolution and severity from the global brain ischemia, the latter mimicking
brain injury following cardiac arrest/resuscitation.
It was therefore our goal in this study to test the preclinical efficacy of this therapy
in focal brain ischemia (stroke) using the rat middle cerebral artery occlusion (MCAO)
model. We hypothesize that dual-wavelength NIR applied during reperfusion following
stroke will provide profound neuroprotection as shown through significant reductions in
infarct volume measured by multiple, clinically translatable MRI modalities. We also
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hypothesized that NIR therapy would directly target salvageable penumbral tissue which
would be measured by a significant perfusion/diffusion mismatch. Furthermore, we
sought to uncover whether two treatment durations of NIR would influence infarct size at
the acute, subacute and chronic time points. Building on our previous data, our first aim
was to modulate mitochondrial activity for 120 minutes, initiated at reperfusion, to limit
ROS bursts during early reperfusion. We next sought to extend treatment duration to 240
minutes, building on the results from the hypothermia literature.
Materials and Methods
Chemicals, reagents, and diodes
Chemicals and reagents were obtained from Sigma-Aldrich (St. Luis, Montana,
USA) unless otherwise stated. Light emitting diodes (LEDs) were obtained from Roithner
Lasertechnik (Vienna, Austria). For animal experiments LED array 60 chips were used
(750 nm, LED750-66-60; 950 nm, LED950-66-60). Diodes were mounted on heat sinks
(black aluminum, 47x20 for LED array 60 chips) together with a small fan (EC3010M05X;
Evercool, New Taipei City, Taiwan) operated in reverse mode. Diodes were calibrated
with an optical power and energy meter (842-PE; Newport, Irvine, California, USA) and
operated with an energy density of 200 mW/cm2.
Experimental Design
Animal use protocols were approved by the Wayne State University Institutional
Animal Care and Use Committee and all experiments were performed in accordance with
the IACUC protocol and relevant regulations. Animals were given free access to food and
water prior to surgery and all surgical procedures were held around the same time of day
to prevent confounding effects of daily humoral cycles. Animals underwent 90 minutes of
transient right middle cerebral artery occlusion as described below. One hour into
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ischemia, animals were placed in the MRI and arterial spin labeling (ASL) and diffusion
weighted imaging (DWI) sequences were obtained. Animals were allowed to recover from
the anesthesia until a few minutes before the 90-minute ischemic period was to end at
which time they were re-anesthetized and the incision opened. After 90 minutes, the
filament was withdrawn and treatment immediately initiated for 120 minutes. Following
the treatment duration, animals were taken off the isoflurane and transported again to the
MRI where ASL and DWI scans were obtained. Following these scans, the animals were
given a subcutaneous injection of buprenorphine (0.015mg/kg) in 10 cc of saline and
allowed to recover in a temperature/humidity controlled environment. Twenty-four hours
following reperfusion the following MRI sequences were obtained: ASL, DWI, T2 weighted
imaging (the transverse, spin-spin relaxation time). After these scans animals were given
15 cc of subcutaneous dextrose injections (5% in 0.95% NaCl) twice a day as we found
a reduction in water intake because of stroke. On days 7 and 14 the animals were again
imaged and the above-mentioned scans acquired. On day 14, following the MRI scans,
animals were sacrificed by transcardial perfusion with phosphate buffered saline followed
by 4% paraformaldehyde. Brains were removed and post-fixed in PFA for 24 hours and
then cryoprotected in a sucrose gradient (20%, 30%) until they were sectioned on a
cryostat at 50 micrometer coronal sections and stained with H&E for histological analysis.
Middle Cerebral Artery Occlusion/Reperfusion
Focal brain ischemia was induced in two randomly assigned groups of male
spontaneously hypertensive rats (223-336 g purchased from Envigo) through the middle
cerebral artery occlusion method as previously described (Uluç, 2011-Longa, 1989). Briefly,
animals were anesthetized with isoflurane (5% induction, 2% maintenance in a mix of
70% nitrous oxide, 30% oxygen). The animals’ temperature was closely monitored by a
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homeothermic blanket (Harvard Apparatus) and kept at 37º C. A neck incision was made
at the midline and underlying connective tissue was removed through blunt dissection
until the common, external, and internal carotid arteries were visualized. The superior
thyroid and occipital arteries, as well as the external carotid were permanently ligated with
a 6-0 silk suture. Next, a commercially available silicon coated tip monofilament suture
(Doccol corporation) was inserted through an incision made in the external carotid and
advanced into the internal carotid artery until it sat at and occluded the origin of the MCA
(18-20 mm from the carotid bifurcation). The suture was secured in place and the incision
quickly sutured and the animal was given subcutaneous injections of lidocaine (20mg/mL
diluted 1:4) around the incision, taken off the isoflurane and allowed to recover in a
temperature- and humidity-controlled chamber for 90 minutes. We found in a pilot study
that 90 minutes of ischemia was the optimal time for causing reproducible infarcts without
increasing animal mortality. Following 90 minutes of ischemia animals were reanesthetized with the above isoflurane protocol, the incision reopened, the filament
withdrawn and NIR treatment immediately initiated (see below).
Administration of NIR Treatment
NIR was administered directly to the intact scalp as previously described
(Sanderson, 2018). Briefly, LEDs were placed 1.5 cm from the scalp which had been
shaved of fur to prevent light loss due to absorbance and reflection. LED intensity was
200 mW/cm2 which converts to 2000 joules/second/meter squared as a dose of energy.
Animals were treated with combined CcO-inhibitory wavelengths of 750nm and 950nm
as it was shown to be most effective by our previous work. Irradiation began immediately
when the filament was withdrawn and continued for 120 minutes (first group) and 240
minutes (second group). During treatment the animals were kept anesthetized on
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isoflurane (1.5%) and on a homeothermic blanket (Harvard Apparatus) which kept core
temperature at 37º C. Control animals underwent the same procedure (duration,
anesthesia) but were not irradiated with NIR. Moreover, Sanderson et al. demonstrated
in vivo that during irradiation with the combined wavelengths, brain temperature remained
constant around 36º C.(Sanderson et al. 2018)
Imaging Procedures and Analysis
All MRI protocols were performed on a 7.0-Tesla, 20-cm bore superconducting
magnet (ClinScan; Bruker, Karlsruhe, Germany) that was interfaced with a Siemens
console. Prior to imaging, animals were anesthetized with isoflurane (4% induction in
room air, 1.75% maintenance). Animals were first subjected to a series of localization
scans. Next, pulsed arterial spin labeling was acquired according to the following
sequence parameters: Relaxation time (TR) of 3500 ms; TE of 16 ms; FoV read 35.0 mm;
FoV phase 81.3%; distance factor 25%; slice thickness 2.0 mm; 4 slices. Next diffusion
weighted imaging (DWI) sequence was conducted according to the following parameters:
TR 10000ms; TE 50 ms; FoV read 32.0mm; FoV phase 100.0%; distance factor 0%; slice
thickness 0.5 mm; 32 slices. Following this a T2 weighted imaging scan was acquired
according to the following parameters: TR 3530 ms; TE 38 ms; FoV read 32 mm; FoV
phase 100.0%; distance factor 0%; slice thickness 1.0 mm; 24 slices. Relative cerebral
blood flow in the MCA territory during ischemia and reperfusion was calculated as
previously described and discussed in Chapter 3. Briefly, voxel intensity in ipsilateral and
contralateral hemispheres was averaged across three coronal slices using ImageJ, giving
the average relative cerebral blood flow (relCBF) voxel intensity value. Then, using the
kinetic model equations, CBF was calculated for both hemispheres giving cerebral blood
flow rates in mL/100g/min. In order to calculate at-risk volume, interspace gap had to be
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considered along with slice thickness when multiplying the sum of hypoperfused areas.
When this was done, it was seen that the volume generated was significantly smaller than
the infarct volume that was calculated at 24 hours which is anatomically impossible. The
slice thickness in ASL sequences is 2 mm apart and the software reports an interspace
gap of 25% in order to account for slice cross talk – or interference between slices during
image reconstruction. When incorporating the interspace gap with the slice thickness,
volumes were still too small and thus a correction factor was derived. Whole brains were
traced from ASL sequences of each animal in the two-hour treatment group using the
relCBF images at 2 hours following reperfusion and areas were summed. Then,
AnalyzePro software generated whole brain volumes from each brain (described below)
using the 2-hour reperfusion DWI sequence. The DWI whole brain volume was divided
by the ASL sum of areas to generate a correction factor for each animal. When the mean
of the correction factors in the group was taken it gave 3.2. Thus, the sum of the ASL atrisk areas were multiplied by 3.2 to give at risk volume in mm3.
Infarct volumes were computed using the semi-automated segmentation tool in
Analyze 11.0 (Biomedical Imaging Resource, Mayo Clinic, Rochester, MN). Seed points
were set in the hyperintense MCA territory and thresholds based on voxel intensity were
set until the entire region was outlined. The software then automatically calculated the
area within that voxel intensity on each slice of the MRI sequence and multiplied the sum
of the areas by slice thickness to generate a volume which was reported as mm3.
Statistical Analysis
Relative cerebral blood flow between groups were compared using an unpaired,
two-tailed t-test with a critical level set to 0.05. Infarct volumes were computed using a
two-way ANOVA with the Neuman-Keuls test for post-hoc analysis. Slopes and intercepts
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of the PWI/DWI mismatch lines were compared by linear regression with significance set
at 0.05. Slopes and intercepts of perfusion/diffusion mismatch lines were compared using
Analysis of Co-variance (ANCOVA) and the Prism graph pad software.
Apomorphine Induced Rotation Test for Functional Recovery
Fourteen days following reperfusion animals that received four hours of NIR
treatment were administered a rotameter test for functional recovery following stroke. The
rotameter measures the number of clockwise turns an animal completes. Because of
unilateral MCA occlusion damage to subcortical structures in the striatum, rats with a
more severe injury will show increased clockwise turns in response to the dopamine
agonist apomorphine. Animals were administered a subcutaneous injection of
apmorphine (1 mg/mL, 0.1 mL per 100 g body weight) and the compound was allowed to
reach peak activity which, according to Modo et al. was 30 minutes following the
injection.(Modo et al. 2000) Then, the animals’ rotations were recorded for 30 minutes
and the number of clockwise rotations summed. We opted to sum the total number of
clockwise rotations rather than do a ration of clockwise over counterclockwise because
animals were not making counterclockwise turns.
Results
Measurements of Relative Cerebral Blood Flow During Ischemia and Reperfusion
Analysis of cerebral blood flow during ischemia and reperfusion were assessed
using arterial spin labeling perfusion weighted MRI (ASL-PWI) in the ipsilateral and
contralateral hemispheres (Figure 1) (Liebeskind 2003, Fau et al 1977, Turrens, et al.
1985, Mitchell and Moyle 1967, Kadenbach et al 2010). During ischemia, all animals
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Figure 1. Relative blood flow during ischemia and following reperfusion. A. Experimental protocol:
untreated control animals and NIR treated experimental animals both underwent MCAO with 90 minutes
of ischemia. 60 minutes into ischemia a pulsed ASL sequence was obtained. Following 90 minutes of
ischemia the filament was removed and treatment initiated for 120 minutes after which time ASL images
were re-acquired. B. Representative ASL scans from both groups both during ischemia and following
reperfusion. C. Averaged regional cerebral blood flow in the ipsilateral MCA territory and contralateral
hemisphere both during ischemia and following reperfusion.

showed significant reductions in blood flow below established relCBF thresholds on the
ipsilateral hemisphere without accompanying changes in flow on the contralateral
hemisphere. Following treatment or no treatment, we repeated ASL scans and confirmed
that the ipsilateral hemisphere was adequately perfused to levels comparable with the
contralateral. Interestingly, there was no significant difference in relCBF between within
the ipsilateral hemispheres of control and treated animals either during ischemia or
reperfusion. Figure 4 shows the relative cerebral blood flow rates for animals treated for
4 hours. The untreated ischemic hemisphere had blood flow reduced to 10.94 mL/100
g/min on average while the contralateral hemisphere maintained physiological flow rates
of 50.78 mL/100 g/min.
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Infarct Volume in the Acute Phase of Stroke
We next looked at the effect of NIR on infarct volume in the acute phase of stroke,
which we defined as 2 hours and 24 hours following MCAO/reperfusion (Figure 2A). Since
DWI has been shown to be the most effective imaging modality both in quantification of
early cytotoxic edema early on during brain ischemia, as well as predictive of final infarct
size, we calculated DWI hypertensities during the acute phase (b=1000). Figure 2B shows
that infarct sizes, which were acquired immediately post treatment (2 hours after
reperfusion), did not significantly differ between NIR treated and control groups, although
the infarct volumes of the treated
animals were more spread than
the untreated controls (control:
256.138

mm3

±

13.16;

NIR

treated: 210.377 mm3 ± 29.09,
p>0.05). At 24 hours following
Figure 2. MRI analysis of cerebral
injury in the acute reperfusion phase.
A. Experimental design: with 2 hours of
treatment. DWI images were obtained
and (B) no significant difference in
infarct volume was seen between NIR
treated and control animals. B
(continued): compared with untreated
controls, NIR treated MCAO rats
showed significant reduction of infarct
volume at 24 hours as measured by
DWI. C. Perfusion diffusion mismatch.
Non-linear relationship was seen
between at risk area analyzed by ASL at
1 hour ischemia (x-axis) and infarcted
area (y-axis) 2 hours following
reperfusion. At 24 hours linearity is seen
where there is a positive correlation
between the at-risk and ischemic areas.
Statistical analysis was conducted by an
unpaired,
two-tailed
t-test
with
significance set at p<0.05.
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reperfusion, animals were re-imaged and based on infarct volumes that were calculated
again using DWI (b=1000), NIR-treated animals showed a significant reduction of 20.5%
in infarct size when compared to untreated controls: 398.86 mm3 ± 20.54 vs. 317.03 mm3
± 23.96, p<0.05 (Figure 2B). The two-way ANOVA also indicated that infarct volumes
were significantly different from 2 to 24 hours between both groups thus suggesting that
the infarcts evolved over time. We next asked whether there was a mismatch between
diffusion and perfusion weighted imaging. We theorized that a mismatch between at-risk
volume calculated during ischemia and ischemic hyperintensities would mean that viable
tissue in the penumbra was being salvaged by the therapy.

Figure 2C shows the

relationship between at risk volume, which was calculated using ASL images 1 hour into
ischemia, and infarcted tissue taken from DWI images at both 2 and 24 hours post
reperfusion. At 2 hours following reperfusion no relationship is seen between at-risk and
ischemic tissue. At 24 hours, however, a positive linear relationship is seen in both treated
and untreated animals suggesting that infarct size could be correlated to the size of atrisk tissue. Despite the linearity of the relationship, the means of infarct volume remained
different even though at risk tissue remains the same between both groups.
Figure 5A shows infarct volumes (in mm3) between NIR treated and untreated
animals, treated with NIR for 4 hours following reperfusion. A significant difference was
seen between two groups in the early reperfusion phase (control group: 228.4 mm3, SD
39.79; NIR treated group: 138.4 mm3, SD 82.623; p=0.0229). Next, DWI hyperintense
lesion volumes were calculated from scans taken 24 hours following reperfusion. A highly
significant 24% reduction in infarct volume was observed between control (351.3 mm3,
SD 51.25) and NIR-treated (266.3 mm3, SD 50.62; p=0.0088) animals. Moreover, a
significant difference was seen in infarct volumes from 4 to 24 hours in both groups as
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calculated by two-way ANOVA indicating that the infarcts continued to evolve from 4 to
24 hours.
Figure 6A shows the perfusion/diffusion mismatch with at-risk area obtained from
pulsed ASL perfusion weighted imaging 60 minutes into ischemia, and area of infarction
obtained from DWI 4 hours following reperfusion. When analysis of covariance was
performed, the slopes of the lines were not significantly different (p=0.41) but the
intercepts were significantly different (p=0.031). 6B shows at-risk area plotted against
area with the area of infarction obtained 24 hours post reperfusion. As at the 4 hour time
point, ANCOVA results indicated that the slopes of the two lines are not significantly
different (p=0.23) while the intercepts are highly significant (p=0.0061). What this means
is that while the distribution of at-risk volumes remains the same between both groups,
the treated animals displayed smaller MRI-measured infarcts. This indicates to us that
tissue that was at risk to become infarcted following reperfusion was salvaged by the
therapeutic intervention.
Infarct Volume in the Chronic Phase of Stroke
Early therapeutic efficacy in the context of stroke has shown promise acutely but
diminished in chronic stroke.(Schellinger et al. 2012; Lees et al. 2012; Mergenthaler and
Meisel 2012; Gladstone, Black Se Fau - Hakim, and Hakim 2002; Lapchak, Zhang Jh Fau
- Noble-Haeusslein, and Noble-Haeusslein 2013) Thus, it was necessary to assess
whether the therapeutic benefits of NIR in reducing infarct size were maintained during
the chronic phase of stroke. To accomplish this, T2 weighted MRI images were acquired
at 7 and 14 days following MCAO/reperfusion (Figure 3A). Seven days following MCAO
NIR treated animals maintained a significant 25.4% reduction in infarct size when
compared to untreated control animals: 363.3 mm3 vs 270.7 mm3, p=0.015 (Figure 3B).
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Fourteen days after MCAO
and prior to sacrificing the
animals, T2WI images were
acquired

and

a

significant

reduction of infarct size of
24.9% between control and
treated animals was observed:
316.9 mm3 vs. 240.8 mm3,
p=0.015

(Figure

3B).

Furthermore, there was no
significant difference in infarct
volumes from 7 to 14 days.
These

data

demonstrate

significant reduction in infarct
volumes,

as

multiple

MRI

measured

by

modalities,

following NIR treatment both
acutely

and

chronically

following

MCAO/reperfusion;

however, as measured by the

Figure 3. Cerebral infarct in chronic phase of post-stroke
reperfusion injury. A. experimental design: 7 and 14 days
following reperfusion T2WI images were acquired. B. 7 days.
Compared with untreated controls, NIR treated MCAO rats
showed a significant reduction in infarct volume. Significant
reduction in infarct volume persisted to 14 days post stroke.
Statistical analysis was conducted by an unpaired, two-tailed t-test
with significance set at p<0.05. C. PWI/DWI mismatch.

ANOVA, the infarcts remained
fully evolved by 7 days even though the treatment effect remained to 14 days. We
analyzed the relationship between at-risk tissue (PWI) and infarcted tissue (T2WI) during
the chronic phase of stroke and found that despite an even spread of the data along the
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x-axis (indicating a range of at-risk volumes during ischemia), there was reduced infarcted
volume in the NIR treated group (Figure 3C) at both 7 and 14 days post reperfusion.
We next assessed whether a 4 hour treatment duration would improve the
neuroprotective effect by targeting the acute and chronic phases of reperfusion injury.
Using T2 weighted imaging, control and NIR treated animals were scanned 7 days
following reperfusion (Figure 3A). T2 hyperintensities yielded a highly significant 48%
difference in volume between control (449.3 mm3, SD 16.4) and NIR-treated (234.8 mm3,
SD 111.2) animals (p=0.0056). We next asked whether this difference would persist to
14 days following reperfusion. As shown in Figure 3B, using T2 weighted imaging, infarct
volumes showed a significant 48% reduction in stroke size between control and NIR
treated animals (control: 339.9 mm^3, SD 73.92; NIR treated: 178.4 mm^3, SD 113.3;
p=0.036) with no significant difference in infarct evolution from 7 to 14 days.
We next examined the PWI/DWI mismatch during the chronic phase of 4-hour
treated animals. Figure 6C shows at risk area plotted with infarction area at 7 days.
Slopes remain non-significant (p=0.34) while intercepts show significant difference
(p=0.018). Figure 6D shows at-risk area plotted against area of infarction at 14 days.
Two-Hour Treatment Histology
At 14 days animals were sacrificed and transcardially perfused as described
above. Due to the variability in tissue integrity following the staining protocol, we
measured the volume of non-infarcted tissue on the ipsilateral hemisphere rather than the
infarct volume. Because infarcted tissue is fragile 14 days after injury, accurate
assessment of the tissue was not precise. Figure 4 shows the volume of non-ischemic
tissue reported in mm3. NIR-treated animals had significantly more non-infarcted tissue
on the ipsilateral hemisphere than untreated controls (237.4 mm3, SD 29.95 vs. 200 mm3,
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SD 17.44; p=0.042).

Figure 4. Histological analysis 14 days post-stroke. Volume of non-ischemic ipsilateral hemisphere
tissue calculated from H&E stained tissue slices. NIR-treated animals had significantly more non-ischemic
tissue in the ipsilateral hemisphere than untreated controls.

Apomorphine-Induced Rotation Test for Functional Recovery
We next looked at whether NIR treated animals showed evidence of functional
recovery in addition to having smaller infarct volumes both acutely and chronically (Figure
5). No significant difference was seen between control and treated animals (control: 119,
SD 49.74; NIR treated: 83.14, SD 56.05; p=0.28).
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Figure 5. Relative cerebral blood flow during ischemia and following a 4 hour NIR treatment.
Averaged regional relative cerebral blood flow in the ipsilateral and contralateral MCA territories during
ischemia and following 4 hours of reperfusion. The untreated ischemic hemispheres showed average flow
rates of 10.94 mL/100 g/min while the contralateral hemisphere had flow rates of 50.78 mL/100 g/min.
Those animals that would receive NIR treatment had ipsilateral MCA territory flow rates 12.125
mL/100g/min during ischemia while the contralateral hemisphere had 53.8 mL/100 g/min. Following
reperfusion, ipsilateral hemispheres of untreated animals had an average flow rate of 85.92 mL/100 g/min
while the contralateral side had 62.04 mL/100 g/min. The ipsilateral hemispheres of the NIR treated animals
had flow rates of 86.03 mL/100 g/min following 4 hours of reperfusion while the contralateral hemisphere
had 63.8 mL/100 g/min.
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Figure 6. A. Infarct volumes in the acute
phase of stroke in MCAO rats treated for
4 hours. Diffusion weighted imaging data
was
acquired
4
hours
following
reperfusion. Results are reported as infarct
volume in mm3 and were based on DWI
hyperintensities. A significant difference
was seen between control animals (228.4
mm3, SD 39.79) and NIR-treated animals
(138.4, SD 82.23), p=0.023. B. DWI-based
infarct volumes 24-hours following
reperfusion. A significant difference
between control animals (351.3 mm3, SD
51.25) and NIR-treated animals (266.3
mm3, SD 50.62) was observed in the acute
phase
of
stroke,
p=0.0088.
Perfusion/Diffusion mismatch. C, at-risk
area during ischemia vs area of infarction
at 4 hours following reperfusion plotted
against area of infarction. The slopes of the
two lines are non-significantly different
(p=0.41); the intercepts of the lines are
significantly different (p=0.031). D. At risk
area vs infarction 24 hours following
reperfusion. Slopes of the lines are not
significantly different (p=0.23); intercepts
are significantly different (p=0.0061)
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Figure 7. T2 Weighted imaging
infarct volumes during the chronic
phase of stroke in MCAO rats. A.
Seven days following reperfusion, NIR
treated animals showed a significant
difference in infarct volume when
compared with untreated controls
(control: 449.3 mm3, SD 16.4; NIR
treated: 234.8 mm3, SD 111.2). B.
Fourteen days following reperfusion,
the significant difference seen at 7
days persisted (control: 339.9 mm3, SD
73.92; NIR treated: 178.4 mm3, SD
113.3). C. At risk area vs area of
infarction 7 days post reperfusion.
Slope of the lines is not significantly
different (p=0.34); intercepts show
significant difference (p=0.018). D. At
risk vs infarction 14 days following
reperfusion.

Figure 8. Apomorphine induced rotation behavioral test
data. NIR treated animals trended towards fewer clockwise
rotations when given apomorphine than untreated controls
(control: 199, SD 49.74; NIR treated: 84.17, SD 61.33; p= 0.28).
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CHAPTER 5 - DISCUSSION: APPLICATIONS AND FUTURE DIRECTIONS
Discussion
Ischemic stroke accounts for about 9% of deaths globally and is the second leading
cause of death following heart disease. Those who survive this debilitating disease often
face a lifetime of neurological deficits and hence a drastic reduction in quality of life. Unlike
other diseases, neurological pathologies such as stroke can affect all aspects of a
person’s life – cognitive, emotional and functional – and in many ways hinder his or her
ability to live fully. Stroke treatment has come a long way in the last several decades
though there is still much work to be done. What once was palliative and supportive care
has burgeoned into nuanced and individualized paradigms tailored to each patient’s
disease and prognosis.
The gold standard for stroke treatment is rapid restoration of blood flow in order to
reverse neuronal injury and cell death, though this can perpetuate brain injury through the
production of ROS during early reperfusion, though this is not the only detrimental effect
of reperfusion. Oxidative stress is a common pathological mechanism in many disease
states which arises from an imbalance between ROS production and ROS scavenging.
Once produced, ROS damage cells either directly, or through diverse and complex cell
signaling cascades damage DNA, proteins and lipids.(Zimmerman 1995) In chapter 1 of
this work we laid out a theoretical framework in which we argued that ROS production is
exponentially related to mitochondrial membrane potential. Membrane potential, in turn,
is subject to fluctuations in both substrate availability, and, in higher organisms, posttranslational modifications such as changes in the phosphorylation states of ETC
enzymes. We argued that enzymatic dephosphorylation during ischemia led to priming
for hyperactivation which, upon reperfusion, resulted in large increases in membrane
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potential and bursts of ROS. It has thus become a critical objective of both stroke
clinicians and stroke researchers to target reperfusion injury at its source and therefore
to save neurons. Pharmacologic agents targeting ROS have been shown to be ineffective
and thus an adjuvant therapy to tPA or thrombectomy is critically needed to target
reperfusion injury.
In this study we sought to show the effectiveness of targeting ROS at their source:
directly in the mitochondrial electron transport chain during the early period of blood flow
restoration using infrared light therapy. Building on our previous work, we reasoned that
this therapy is noninvasive, can be applied immediately at the onset of reperfusion and
has shown to have sufficient penetrating depth to target brain tissue during reperfusion.
We hypothesized that irradiation of the brain with combination dual wavelength NIR
immediately upon reperfusion would reduce infarct size both acutely and chronically in
stroke. Since this therapy targets the penumbra rather than the stroke core, we first
needed to demonstrate that the MCA territory was sufficiently hypoperfused. Our data
indicate that cerebral blood flow which was averaged across three slices of perfusion
weighted MRI is significantly reduced below ischemic thresholds in the ipsilateral
hemisphere and returns to normal levels following reperfusion. Interestingly, infarct
volumes were not different between treated and control animals immediately following
treatment when animals were treated for 120 minutes but animals treated for 240 minutes
showed significant reductions in infarct volume when compared to untreated controls.
Importantly, these significant reductions in infarct volume persisted in both treatmentduration groups when 24 hour DWI scans were taken. This suggests that NIR targets
ROS-mediated pathways in the delayed neuronal death cascade that extends beyond the
initial 120 minutes of reperfusion. While this suggests that neurons in the penumbra were
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being salvaged by NIR therapy, we needed to confirm this by examining whether a
significant mismatch existed between perfusion and diffusion weighted imaging. In
chapter 3 of this dissertation we outlined a long-standing argument in neuroimaging that
any difference between at-risk tissue and infarcted tissue as measured by perfusion and
diffusion MRI modalities respectively could be considered a measure of hypoperfused
areas that have not yet died and thus could be potentially salvaged. When we plotted atrisk area against area of infarction in both the 120 minute and 240 minute treated groups,
we saw non-significant slopes but statistically significant intercepts. A non-significant
slope indicates that the rate of change between the two variables in both groups is the
same – the lines are parallel. This suggests that the relationship between area at risk and
area of infarction is linear, i.e., the area of infarction is proportional to the area at risk and
this holds true for both treated and untreated groups. The elevation of the two lines,
however, is significantly different indicating to us a mismatch between at-risk and
infarction in treated animals. This finding allows us to conclude that in both the 120 minute
and 240 minute NIR treated animals, neurons in the penumbra are being salvaged by our
approach which results in significantly smaller infarct volumes overall at both 4 hours (in
the 240 minute treated group) and 24 hours (in both groups).
We next asked whether the benefit of NIR could be extended into the chronic
phase of stroke. Our data show that infarct volumes as measured by T2WI remained
significantly smaller at 7 and 14 days post stroke in both 120 and 240 minute NIR treated
animals. Moreover, PWI/DWI mismatches had intercepts that remained significantly
smaller in both groups when compared to untreated controls. The animals treated for 240
minutes had significant reductions in infarct volumes of about 50% at 7 and 14 days
indicating to us that extending treatment duration significantly improves neurological
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outcome as measured by clinically translatable imaging modalities. Additional targeting
of late-stage ROS production caused by excitotoxicity, inhibition of inflammatory cell
conversion through ROS signaling in the immune cell as well as longer than predicted
window of mitochondrial stress and other, unknown mechanisms can all potentially
explain how the longer treatment duration had such profound reductions in infarct volume
during the chronic phase of stroke.
Finally, in the animals treated for 240 minutes we employed an apomorphineinduced rotational test to see whether changes in infarct volume correlated to observable
functional improvements in neurological function. Apomorphine is a non-selective
dopamine agonist which exerts its action on D2-like and D1-like receptors. Unilateral
striatal lesions lead to increased rotation in one direction when striatal dopaminergic
neurons are agonized. Our data indicate that while on average 4-hour NIR treated
animals had fewer rotations than untreated controls, these results were not statistically
different. This data is promising and likely due to the large amount of variability seen in
behavioral tests and the need for large sample sizes that are not feasible in such a
study.(Rewell et al. 2017)
Conclusions
In conclusion, this is the first study of its kind demonstrating in the rat MCAO model
that immediate, reversible, non-invasive inhibition of photoreceptive mitochondrial CcO
by dual-wavelength NIR in vivo during reperfusion following focal stroke can have
profound and sustained reductions in tissue death. Furthermore, these reductions in
infarct volume were measured by clinically relevant MRI modalities, which allowed
assessment of stroke evolution over time to be monitored in vivo and in real time as is
done in the clinic. Thus, based on our previous work demonstrating that NIR treatment
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limits mitochondrial ROS production when applied during reperfusion after global brain
ischemia, we here demonstrate that such treatment reduces the progression of
reperfusion injury following focal brain ischemia and thereby minimized brain damage
caused by stroke. Furthermore, this work has shown that NIR can target more than the
initial burst of ROS following reperfusion. Extending treatment duration to 240 minutes
had profound effects on infarct volume that were sustained during the chronic phase of
the stroke. It is likely that this is due to NIR affecting the immune response. As a result,
this project has shifted the paradigm on the role that NIR can play at longer stages of the
reperfusion injury process. Future studies ought to examine the effect of NIR on immune
responses, and other potential long-duration targets of NIR in other brain
ischemia/reperfusion pathologies
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Acute ischemic stroke is a debilitating disease that causes significant brain injury.
While rapid restoration of blood flow is critical to salvage the ischemic brain, reperfusion
of tissue can further drive brain damage by inducing generation of mitochondrial reactive
oxygen species (Chouchani et al., 2014a). Recent studies by our group found that noninvasive mitochondrial modulation (NIMM) with near-infrared (NIR) light can limit the
production of reactive oxygen species following global brain ischemia (T. H. Sanderson
et al., 2018). NIR interacts with the rate limiting step of the mitochondrial electron
transport chain (ETC), cytochrome c oxidase (COX), and modulates mitochondrial
respiration. Under conditions of mitochondrial stress, such as reperfusion following
ischemia, specific wavelengths of NIR can limit the production of ROS by transiently
reducing COX activity, and thus limiting a critical force for ROS production, stress-induced
mitochondrial membrane potential hyperpolarization. Here, we evaluated a specific
combination of COX-inhibitory NIR (750nm and 950nm) as a potential therapy for acute
ischemic stroke using a rat MCAO model. We found the NIMM at the onset of reperfusion
resulted in a 20% reduction of infarct volume measured 24 hours post reperfusion. This
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reduction in infarct was sustained through the chronic phase of stroke and the
neuroprotective benefit increased to 50% infarct reduction when treatment duration was
douple to 240 minutes. Our data suggest that NIMM by targeting COX with NIR irradiation
at the onset of reperfusion can be a beneficial therapy to minimize reperfusion injury
following acute ischemic stroke and that extending the treatment window beyond the
initial ROS burst can target other long-term causes of neuronal death following stroke
such as inflammation.

108
AUTOBIOGRAPHICAL STATEMENT
CHRISTOS DIONISOS STRUBAKOS
EDUCATION
September 2018 PhD in Physiology, Wayne State University, Michigan
June 2012 EMT-B Training, Boston EMS
May 2012 Holy Cross Greek Orthodox School of Theology, Master of Divinity Theology (Summa
Cum Laude) Massachusetts
March 2012 BLS Certified, American Heart Association Boston EMS, Massachusetts
June 2010 University of Windsor Honors Bachelor of Arts (Cum Laude).
Major: Classics and Psychology
SCIENTIFIC RESEARCH EXPERIENCE
Clinical
Henry Ford Hospital, Detroit, Michigan. Department of Neurology. Clinical research
examining cardiac dysfunction following acute stroke using MRI and patient clinical data.
Dr. Panayiotis Mitsias, Advisor.
September 2012-Present
Basic Science
Wayne State University, Detroit, Michigan. Department of Physics and Astronomy.
Single Molecule Biophysics and Biomedical Physics
Project: in vitro actin bundling and polymerization visualized using TIRF microscopy
Dr. Takeshi Sakamoto, Advisor.
May 2013-August 2015
Wayne State University, Detroit, Michigan. Department of Emergency Medicine and
Physiology.
Project: Translational research in focal ischemia using rat model
Drs. Maik Huttemann and Thomas Sanderson, Advisors
January 2015- Present
SCIENTIFIC MEETINGS
February 2015: International Stroke Conference, Nashville TN. Poster
Specific Infarct Locations Define Troponin Elevation in Acute Ischemic Stroke
Panayiotis D. Mitsias, MD, PhD, Christos Strubakos, Ahmed Dakka, Patricia Penstone,
RN, Kourosh Jafari, PhD, Lonni Schultz, PhD, Hamid Soltanian-Zadeh, PhD

